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Partners play a critical role in making decisions about fertility preservation among 
young patients with cancer, yet little is known about these dyadic decisions when 
planning cancer treatment. Fertility preservation entails helping cancer patients preserve 
fertility after cancer treatment. This qualitative study investigated: 1) Heterosexual 
couples’ responses to potential fertility loss; 2) their process in making fertility 
preservation decisions; 3) their ethical and legal concerns, and 4) recommendations for 
other couples undergoing similar treatment. 
Semi-structured interviews were conducted with 12 heterosexual couples whose 
female partners were diagnosed with cancer and had received fertility preservation 
consultations within the past 5 years. Interviews were recorded, transcribed, and analyzed 
using grounded theory methods.  
The results indicated that couples have varied reactions to infertility. In most, 
spouses let the patients take the lead in, and supported, their fertility preservation 
decisions. Spouses recommended support to patients.  
Couples face challenges in making fertility preservation decisions. Input from, 
and support for, both partners is essential to ensure well-informed, high-quality fertility 







I would like to thank all of the participants who took part in the study willingly 
and whole heartedly. This is a sensitive topic and it is never easy to share these stories. I 
am very thankful to all my committee members for their feedback and guidance. I would 
especially like to thank Dr. Terri Woodard for giving me this opportunity at the MD 
Anderson Research Center. I also would like to express my gratitude to my advisor, Dr. 
E. Roberto Orellana, for his guidance and lending a patient ear to my struggles. I 
appreciate Dr. Pauline Jivanjee truly for her feedback and challenging me to produce an 
improved work.  
Many thanks and heartfelt gratitude to my husband, Saurabh, for encouraging me 
to pursue this endeavor and supporting me through the process. Despite his own busy 
schedule, there were times when he assumed the full responsibility for our children so I 
could focus on my work. 









Table of Contents 
Abstract ……………………………..…………………………………….……........ i 
Acknowledgements………………………………….…………………….…………ii 
List of Tables ……......................................................................................................iv 
List of Figures ……......................................................................................................v 
Chapter 1: Introduction……..………………………………………………………...1 
Chapter 2: Literature Review…………………………………………………………9 
Chapter 3: Theoretical Framework……………….………………………………….34 
Chapter 4: Research Questions and Methods..…………………………………..…..41 
Chapter 5: Results..…………………………………………………………….....….51 
Chapter 6: Discussion………………………………………………………………..73 
References……………………………………………………………………………96 
Appendix A: Demographic Questionnaire.......…..……………………………........113 
Appendix B: Interview guide……………...……………..........................................118 
Appendix C: Consent Form…….…………………………..…………....................123 






List of Tables 







List of Figures  
Figure 1. Ottawa Decision Support Framework…………………………………….93 
Figure 2. Visual of Themes………………………………………………………….94 





Chapter 1: Introduction 
Background of the problem 
Approximately 409.9 women per 100,000 people annually will develop cancer, 
and of these, 67.5 % will survive (Noone et al., 2018). However, cancer treatment may 
lead to infertility among young women and a deterioration in their quality of life 
attributable to cancer-related stress (Woodard & Hoffman, 2017; Schover, Rybicki, 
Martin, & Bringelsen, 1999).  
Infertility related to cancer treatment has received increasing attention in the past 
ten years. Women often delay pregnancy until their thirties and realize that cancer 
jeopardizes their reproductive life plans (Canada & Schover, 2012).  
Certain cancer treatments, including surgical removal of the reproductive organs, 
chemotherapy, or radiation, affect a woman’s reproductive capacity. These effects may 
be temporary (treatment) or permanent (surgery) and can lead to compromised fertility 
immediately or in the future (Mayo Clinic Staff, 2014). Schover et al.’s (1999) study 
reported that 76% of younger cancer survivors without children not only expressed a 
desire to have children, but also were concerned about their potential reduction in 
fertility, possible treatment-related complications during pregnancy, and neonatal 
outcomes. The American Society of Clinical Oncology (ASCO) has recommended that 
oncologists discuss the possibility of infertility with reproductive-age cancer patients and 
offer referral for Fertility Preservation (FP) consultation and therapy. FP is an emerging 
field that provides treatment designed to protect the future reproductive viability of 
individuals with cancer or other serious illnesses. Although FP strategies vary according 
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to the patient’s age and sex, some allow patients to store gametes or reproductive tissues 
for future use (Jensen, Morbeck, & Coddington, 2011). However, young women with 
cancer face many difficult decisions with respect to FP; they have different treatment 
paths and circumstances under which they may have to make this decision, and may be 
affected by the expected outcomes of the treatment they are undergoing. For example, 
some women treated for cervical cancer are unable to become pregnant because they 
have had a radical hysterectomy or a large dose of pelvic radiotherapy. Their decision to 
pursue FP may include considerations such as expensive treatment and help from 
surrogacy. Others in the early stages of the disease may be eligible for fertility-sparing 
surgical options, such as conization or trachelectomy. Trachelectomy is a surgical 
procedure for the early stages of cancer to protect fertility among women after the 
treatment. Irradiation of the uterus also can cause pregnancy complications, including 
miscarriage, premature birth, and low birth weights, which may dissuade women further 
from reproducing (Canada & Schover, 2012). Other factors that may influence their 
decisions include occult damage to the heart or lung function after cancer treatment that 
can manifest in acute illness combined with the physiological stress of pregnancy. Some 
women opt out of pregnancy because they fear cancer recurrence or having a child with 
birth defects, although a large epidemiological study has shown no link between the 
effects of cancer treatment and giving birth to children predisposed to congenital 
abnormalities or even cancer itself, apart from those with familial malignant diseases 
(Hawkins, Draper, & Smith, 1989). 
FP Decision Making 
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Young women with cancer whose fertility may be at risk face difficult decisions 
regarding FP, and very few studies have examined this decision-making process. 
Following diagnosis of early breast cancer, women need to make rapid decisions 
regarding fertility interventions before beginning treatment (Peate & Meiser, 2012). The 
complexity of making FP decisions increases when ill-defined risk factors are present, 
such as fertility-treatment-induced increases in ovarian sex-steroid levels, which are 
contraindicated in women with breast cancer (Lee et al., 2006; Oktay et al., 2005; 
Partridge et al., 2007). Therefore, it is vital that clear and current information about 
fertility is provided in a timely manner (Peate & Meiser, 2012) 
There are several components in FP decision-making. Once the patients are 
informed that their fertility may be compromised, they face several dilemmas, including 
whether to opt for FP, whether it is worth paying for the treatment, whether they will be 
able to use their preserved eggs in the future, whether they are too young to preserve 
eggs, or whether they should opt for a sperm donor. These are but a few of the many 
questions that patients face when undergoing treatment that may cause infertility. The 
process of making decisions requires not only gathering information, but also seeking 
support from healthcare providers, family members, friends, and others. It is difficult for 
any single support system, whether it is family or a healthcare system, to provide all that 
is required in making such decisions. Patients also feel isolated while going through the 
process, as they find themselves at times in a unique position in which they know no one 
who has gone through a similar experience. They also face difficulties at various stages 
of decision-making, beginning in the first stage, when their physician provides them 
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information about FP, to the final act of FP. Hence, there is a need to provide patients 
with support and help guide them as they make FP decisions. 
For the purpose of this study, the female partner with cancer is referred to as the 
patient and her husband/life partner is referred to as the spouse/partner. A qualitative 
study which included individual interviews with patients and their spouses was conducted 
to explore FP decision making among young patients.  
Research objective 
This dissertation explored the following questions: 
1) How does the knowledge of the potential risk of infertility affect couples? 
2) What role do spouses/partners play in FP decision-making? 
3) How are decisions negotiated? 
4) What are the partners’ ethical and legal concerns? 
The primary objective of the study was to explore the role spouses play in FP 
decision-making. 
This research explored factors and priorities that patients with cancer and their 
spouses/partners use to make decisions about FP. Findings from this research may help 
develop educational information and prepare such patient support tools as decision aids 
(DAs), develop interventions, such as counselling sessions, and organize support groups 
that will help patients make informed decisions about FP.  
Studies have shown that educational materials, videos, pamphlets, and DAs help 
patients make decisions. For example, a meta-analysis of the literature was conducted to 
measure the effectiveness of cancer-related DAs. DAs improved knowledge about 
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treatment options significantly by comparison to usual practices, and reduced anxiety and 
decisional conflict overall in decision-making (O’Brien, Whelan, Villasis-Keever, Gafni, 
Charles, & Roberts, 2009). These aids do not advise people to choose one option over 
another, nor are they meant to replace consultation with practitioners. Instead, they 
prepare patients to make informed, value-based decisions with their practitioners. To 
develop such tools for use with FP, a formal study is needed to explore the spouse/patient 
FP decision-making process. These assessments are even required by some organizations, 
such as the International Patient Decision Aids Standards collaboration (IPDAS), as a 
part of a systematic process to develop such tools as DAs. This study will provide 
information that will help develop educational material, including DAs and interventions 
to improve support for affected women. 
Importance of the Study 
This dissertation focused on the role of spouses/partners in fertility decision-
making on the part of young women with cancer. The study is relevant for women who 
are a part of a couple or have significant others. Women may make FP decisions 
individually, for example egg freezing; however, this study focused on couples who make 
decisions together. While multiple factors are involved, spouses/partners play a critical 
role in making fertility decision choices. For younger men, sperm freezing is considered a 
simple and highly successful FP strategy (Anderson et al., 2008) regardless of the 
recovery expectation of spermatogenesis (Peddie, Porter, Barbour, Culligan, MacDonald, 
& King, 2012). Women who survive cancer may recover their fertility after completing 
treatment and retain reproductive function. However, fertility-related discussions become 
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complicated when they reach the point of current relationship status, plans for children, 
and the range of FP options available. This may hinder providing information to the 
patients timely (Duffy et al., 2005; Quinn et al., 2007, 2008). Other studies have 
suggested that young early breast cancer patients have unmet needs for information 
related to fertility (Knobf, 2001; Partridge et al., 2004; Thewes et al., 2003, 2004, 2005 ). 
Peate et al. (2012) identified a gap in the literature about the spouse/partner’s role 
in FP decision-making and stated: 
Most participants reported that their partners were involved in the fertility 
treatment decision-making process, yet very little is known about how 
partners perceive their role despite fertility-related decisions being a 
decision for both parties. Understanding the mechanisms of fertility-
related decision-making should incorporate this factor. (p. 106) 
Most research in the area of FP has used data collected from women only. The 
reasons men were included in this study are: First, data from earlier studies have 
suggested that women seek support from family in decision-making, in which the spouse 
has a strong influence. Second, fertility and family-planning research has found that men 
and women have different attitudes about fertility that may have an influence on FP 
decision-making overall. Third, the literature also has suggested that men are more 
invested in having biological children than are women. Fourth, little literature is available 
on the spousal role in making FP decisions. Fifth, understanding spousal influence will 
help educate and provide support to couples as they make these decisions.  
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Women’s fertility choices affect men’s lives as well, from becoming a father and 
the finances required to support children, to changes in their social status. Culturally, 
spouses have a strong influence on a women’s choice to become a mother, and failure to 
involve them in decision-making may have serious implications. Despite educating 
women about FP methods, they may not opt for it if their spouses/partners oppose the 
decision. Hence, it is important to include the spouse/partner’s perspective in FP 
decision-making. This dissertation will fill the gap in knowledge about the 
spouses/partner’s role in FP decision-making on the part of young women with cancer. 
This research explored this role by focusing on their preferences with respect to 
FP methods, whether they are aware of the various methods, and the way their future 
family goals compare with those of their spouses/partners. It is important to know 
whether both parties are knowledgeable about FP methods. 
Importance of the Study in the Field of Social Work 
 Oncofertility is an interdisciplinary field (Atman, Ma, Duncan, & Woodruff, 
2018) and is described in detail in the literature review. This field requires cross 
discipline interactions inherently (Atman, et al., 2018), in which social work input is 
critical. This study is a part of the effort to contribute to this fast-growing field.  
Responsiveness to individual needs is critical in FP decision-making (Logan, 
Perz, Usser, Peate, & Anazoda, 2018). One of the goals of the study was to understand 
the patients’ and their spouses’ individual needs to make optimal decisions related to FP.     
 Studies have suggested that infertility is associated with long-term distress 
among women. Infertility after cancer treatment affects quality of life adversely and leads 
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to emotional distress (Schover, 2005), and mere information about FP may not help in 
decision-making. Partridge et al. (2004) suggested that “…compared with participants 
who received usual care, those with access to the DA reported higher rates of satisfaction 
with the fertility information received (>70%), which is above the 51% previously 
reported as having their concerns addressed adequately” (p. 4174). Using DA tools leaves 
women more satisfied with their choices and helps them deal with the pain of infertility 
(if any) after chemotherapy (Schwartz et al., 2010). Patients need individualized 
consultation to determine the best and most advance FP technology available in their 
unique circumstances and according to their informed choice (“What Are Social 
Workers’ Roles in Oncofertility?”, 2015). Clinicians may not provide the psychosocial 
support that patients need to make FP decisions because of limited time, and thus, the 
social worker’s role comes to the fore when providing this support. Many social workers 
also provide consultation for patients and serve as a patient navigator who offers support 
and guidance to their patients throughout the FP process as well as coordinates their care. 
An interdisciplinary team may help support the patients and may include oncologists, 
gynecologists, nurses, and social workers.  
To develop counselling aids and training material for patient navigators, formal 
qualitative research needs to be conducted to understand and explore the decision-making 
process among patients and their spouses/partners. This dissertation will help Oncology 
Social Workers be proactive in helping patients who are experiencing infertility 




Chapter 2: Literature Review 
Summary 
         The literature review will cover the current scope of the problem, existing clinical 
practices, guidelines, and the need to develop tools to assist patients with FP decisions. 
This review will examine the extent of the problem and the fact that it is a growing 
burden on the healthcare system. It also will explore and explain the significance and 
societal burden of infertility associated with cancer treatment and the emerging medical 
field of “oncofertility.” The review also will explain what a DA is. Although the 
development of a DA is beyond the scope of this dissertation, the data collected and 
analyzed will be useful in developing DAs and other training materials. 
Scope of the Problem 
According to the American Cancer Society (2018), an estimated 1,735,350 new 
cancer cases will be diagnosed in the US in 2018. The age-adjusted cancer death rate 
overall declined from 215 per 100,000 in 1991 to 159 per 100,000 in 2015 (American 
Cancer Society, 2018). These numbers reflect improvements in diagnosis and treatment 
techniques. At the same time, this success draws attention to the need to focus on 
improving survivors’ quality of life. Healthcare providers’ goal should not be mere 
survivorship, but also the ability to lead a fulfilling life after cancer treatment, which 
includes having children.  
        Infertility and distress 
Certain types of surgeries and radiation increase the risk of infertility among 
young women, and may be temporary or permanent. The effect of treatment on fertility 
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varies according to the dosage administered, the patient’s age, and the type of cancer and 
treatment; however, in any case, it may have a negative effect on cancer survivors’ 
emotional and physical health. Young adults with cancer have reported that infertility is a 
significant health issue that leads to poor psychosocial outcomes (Schwartz et al., 2010). 
Advancements in FP technology can improve the chances of having children post-
treatment and reduce the emotional distress of patients who have undergone cancer 
treatment. According to the ASCO’s guidelines on FP: 
As part of education and informed consent before cancer therapy, health 
care providers (including medical oncologists, radiation oncologists, 
gynecologic oncologists, urologists, hematologists, pediatric oncologists, 
and surgeons) should address the possibility of infertility with patients 
treated during their reproductive years (or with parents or guardians of 
children) and be prepared to discuss FP options and/or to refer all potential 
patients to appropriate reproductive specialists. Although patients may be 
focused initially on their cancer diagnosis, the Update Panel encourages 
providers to advice patients regarding potential threats to fertility as early 
as possible in the treatment process so as to allow for the widest array of 
options for FP. The discussion should be documented. (Loren et al., 2013, 
p. 2500)  
Barriers to Infertility Discussion 
A meta-synthesis of 76 studies on barriers to, and facilitators of, FP care, 
concluded that intrinsic factors related to patients’ current state of health, values, belief 
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systems, and communication behaviors, as well as their families and providers, affect 
discussions related to the potential loss of fertility (Panagiotopoulou, Ghuman, Sandher, 
Herbert, & Stewart, 2018). Earlier studies have reported that fewer than 50% of 
reproductive-age survivors recall discussing fertility risks with a healthcare provider, and 
fewer than 30% received FP therapies (Gwede et al., 2012; Quinn et al., 2009). The FP 
decision-making process is complicated and is associated with many barriers, including a 
lack of discussion of the issue, the urgency of treatment, a cautionary approach to 
experimental procedures, and staff assumptions about patients’ needs (Peddie, Porter, 
Barbour, Culligan, MacDonald, & King, 2012).  
A study was conducted in Japanese clinics to determine provider factors that 
contributed to physicians’ behaviors with respect to FP (Shimizu et al., 2012). Female 
and younger oncologists (< 50 years) had a significantly higher probability of referring 
patients to reproductive specialists, and physicians who had better knowledge scores and 
positive attitudes about FP also were more likely to discuss potential fertility issues with 
cancer patients. According to Gwede et al. (2012), oncologists (i.e., surgical, medical, 
and radiation oncologists) differ in their practice behaviors, specifically referral and 
discussion of FP. There was a significant difference in discussions of the effects of 
treatment on the future fertility for cancer patients of childbearing age depending on 
oncology subspecialty. This research suggested that 82% of radiation oncologists 
“always/often” discussed the effects of treatment on fertility, compared to 51% of 
surgical oncologists. There were no significant differences between oncology specialty 
and referrals to reproductive endocrinologists reported, with 24% to 31% of all 
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oncologist types reporting that they “rarely/never” refer patients of childbearing age to an 
infertility specialist or reproductive endocrinologist (Gwede et al., 2011). In addition to 
the lack of referrals, the risks of recurrence, lack of collaboration with reproductive 
specialists, and time constraints in the clinic were identified as major barriers to 
discussing FP with breast cancer patients (Woodard et al., 2017). According to a study by 
Shimizu et al. (2012), female and younger physicians, as well as physicians who work in 
a multidisciplinary environment, had positive attitudes about FP for breast cancer 
patients. The authors recommended the development of comprehensive and 
interdisciplinary programs to help healthcare providers meet the expectations and fertility 
needs of breast cancer patients (Shimizu, Bando, Kato, Mizota, & Yamamoto, 2012). In 
the last five to ten years, significant efforts have been made to provide information and 
support to patients who are undergoing cancer treatment and may be at risk of infertility.  
Decision-making challenges 
While efforts are made to provide information on the risk of infertility, merely 
providing information does not assure the proper use of FP services. There are barriers to 
such discussions, including late delivery of pertinent information, psychological stress, 
fear of delaying cancer treatment, and cost (Woodard et al., 2017). Studies have shown 
that receiving specialized counseling about reproductive loss and pursuing FP is 
associated with less regret and an improved quality of life on the part of survivors, yet 
few patients receive this potential benefit. Women of reproductive age should have expert 
counseling and should be given the opportunity to make active decisions about preserving 
fertility (Letourneau et al., 2012). Women feel more confident about their decisions when 
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counseled, regardless of whether they choose fertility treatment (Woodard et al., 2017). 
Patients’ access to FP care and information may depend on, and vary by, clinic and 
provider.  
Couples’ decision-making and the role of spouses 
There is a gap in knowledge and information about couples’ FP decision-making, 
and patients need to be supported throughout this process. Hence, specialized counselling 
and tools like DAs may ensure timely introduction of FP options during the initial weeks 
of cancer treatment planning. This dissertation focused on understanding and exploring 
spouses and patients’ roles in the decision-making process. 
Cancer-related infertility 
Many premenopausal women who undergo chemotherapy experience 
chemotherapy-induced amenorrhea (cessation of the menstrual period), premature 
menopause, or infertility. Research has indicated that treatment-related menopause is less 
common in women younger than age 35 and often is related to the type of chemotherapy 
used, the dosage of the drugs, and the patient’s age. Most premenopausal women will 
stop menstruating at least temporarily during or following chemotherapy. While they may 
have symptoms of menopause, using the term “menopause” is avoided, as many regain 
ovarian function even several years later, and even may become pregnant during 
amenorrhea. Instead, many doctors today prefer to use the term “chemotherapy-induced 
amenorrhea,” or CIA (Johns Hopkins University, 2014). 
Infertility leads to emotional distress and personal suffering (Verhaak, Smeenk, 
Evers, Kremer, & Kraaimaat, 2007). Patients with a history of gynecologic cancer who 
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have lost their fertility as a result of cancer treatment experience depression, grief, 
distress, and sexual dysfunction (Carter, Rowland, Chi, Brown, Abu-Rustum, & Castiel, 
2005). They have persistent emotional difficulties accompanied by physical pain and 
distress, which has a negative effect on their quality of life (Carter, Rowland, Chi, 
Brown, Abu-Rustum, & Castiel, 2005). It has been documented well that it is difficult to 
cope with the loss of fertility in itself, and that, coupled with cancer treatment, the issue is 
even more stressful for patients (Carter, Rowland, Chi, Brown, Abu-Rustum, & Castiel, 
2005). Hence, the field of “oncofertility” research emerged.  
Emergence and Brief History of the Field of Oncofertility 
After the 1971 National Cancer Act was signed and new funds were allocated to 
cancer research, there was significant improvement in the survival rate of cancer patients, 
which reached 3.5% of the US population (Woodruff, 2007). As healthcare providers 
began to see improvements in the survival rate, they also observed the increasing problem 
of the long-term side effects of treatment, and FP among young cancer patients emerged 
as a solution to the reproductive future of cancer patients (Woodruff, 2007). 
The term “oncofertility” was introduced in 2006 and was described as a new field 
that focuses on the reproductive health and future of cancer survivors who may face 
infertility as a result of chemotherapy, radiation, or surgery (Woodruff, 2007). 
Oncofertility patients include those in pediatric, adolescent, and young-adult stages of 
life. Oncofertility encompasses: (1) the science needed to develop new FP options for 
patients prior to the onset of cancer treatment; (2) the clinical specialties to integrate FP, 
family building, and hormonal management throughout survivorship, and (3) the 
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academic scholarship to advance oncofertility communication, social science, and 
education (Waimey et al., 2013). In 2007, a book published by Northwestern University 
Medical School explained the term “oncofertility.” It described the emergence of an 
interdisciplinary science that brought together oncologists, fertility specialists, and social 
scientists to provide holistic treatment to help cancer patients live fulfilling lives after 
cancer treatment (Woodruff, 2007). Further, according to Waimey et al. (2013), in 2007, 
the National Institutes of Health (NIH) funded a five-year Roadmap Grant for Medical 
Research to form the Oncofertility Consortium—a comprehensive interdisciplinary 
research effort that addressed the complex biomedical condition of fertility impairment in 
cancer survivors. The Oncofertility Consortium was comprised of researchers based at 
four core centers—Northwestern University, the University of California at San Diego, 
the University of Pennsylvania, and Oregon Health & Science University—and its 
National Physicians Cooperative, which included more than 50 allied healthcare centers 
across the United States that implement oncofertility science and scholarship into the 
clinical setting and provide FP treatments to cancer patients (Woodruff, 2010). The 
Consortium’s objective was to gather professionals from different fields, including 
scientists, clinical specialists, and academicians, to examine and overcome current 
reproductive barriers for cancer patients (Waimey et al., 2013). 
Diverse professionals from various fields have played different roles in the 
advancement of the field. Oncofertility scientists work to improve the basic 
understanding of gamete development and maturation and to apply this understanding to 
FP techniques. Clinical practices and treatment protocols have been discussed and 
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established. After working in group sessions on female and male FP, the advancement in 
the field and future opportunities over the following few years were discussed and 
documented (Waimey, 2013), as were different cases and scenarios. In discussing the 
current state of female FP research, participants recognized that, for women, embryo 
banking is the most mature FP technology, but it is not optimal for all females, including 
prepubertal girls and women who need immediate treatment, women with hormone-
sensitive cancers, or those who lack an available and suitable sperm donor (Ata et al., 
2010; Duncan et al., 2011). Although advances in the fast-freezing vitrification of 
oocytes have led to increased success rates in oocyte banking, this technique still requires 
hormonal stimulation of patients to retrieve the oocytes, which may not be feasible for 
girls and some women (Noyes, Boldt, & Nagy, 2010). Apart from the options mentioned 
above, an alternative is ovarian tissue cryopreservation that may cater to the needs of 
women and girls who cannot opt either for embryo or oocyte banking (Donnez et al., 
2010, 2011). FP options historically have been available more readily for males than for 
females because of the relatively straightforward technique of sperm cryopreservation for 
post-pubertal males established in the 1970s (Glaser, Wilkey, & Greenberg, 2000). 
Hence, recent research in FP has focused on the need to provide equal and similar care to 
women, despite more clinical efforts needed to ensure male patients’ use of FP (Waimey, 
2013). 
Because we know that cancer therapy improves a patient’s survival but affects 
reproductive health, FP now is an option available to patients to overcome the problem of 
infertility resulting from cancer treatment. Of the estimated 1.5 million men and women 
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who were diagnosed with cancer in 2010, approximately 10% were younger than 45 
years. For these individuals, cancer treatment can be lifesaving, but can affect 
reproductive capacity permanently (Jensen, Morbeck, & Coddington, 2011). However, 
fewer than 5% of adults with cancer choose to protect their future fertility by having 
samples of their gametes frozen before undergoing treatment (Editorial, Lancet, April 
2014, p. 361). Thus, there is a gap between the need for, and use of, FP technology. To 
address the issue of infertility and the growing field of FP technology, several clinical 
guidelines for healthcare providers have been developed to facilitate FP discussions and 
referrals. 
Adolescent and Young Adult Oncology  
The field of oncofertility is consistent with another emerging field, that of 
adolescent and young adult oncology (AYAO), which focuses on advancing research and 
clinical care to improve outcomes for cancer patients who are diagnosed between the 
ages of 15 and 39 years. This population constitutes 10% of all cancer patients and 
survivors of those same ages (Sender, 2011). As these are the primary reproductive years, 
fertility is of significant concern to AYAO patients and their clinicians. The primary 
barrier to care for this age group is that fewer providers discuss fertility options with their 
patients (Clayman et al., 2011; Schover et al., 2002; Sheth et al., 2012). It is important to 
ensure that adolescent and young adult patients are informed of both the fertility and 
hormonal effects of cancer treatment and are made aware as well of their options to 
preserve reproductive function prior to such treatment. At a working group of providers’ 
session, guidelines were set to make clear that oncofertility information be disseminated 
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to oncology practitioners (Waimey, 2013). For example, a comprehensive brochure about 
AYAO patients, including information about fertility and hormonal health, could be 
created. The group agreed that such education should be communicated to a broad range 
of healthcare providers, not just oncologists. Engaging nurses, clinical psychologists, and 
other members of the oncology team would allow individual practices to determine which 
team member providers could discuss oncofertility issues with patients best and provide 
referrals to reproductive specialists (Waimey, 2012). It was suggested that oncofertility 
information could be disseminated to the greater AYAO community through partnerships 
with advocacy groups, such as Stupid Cancer, and professional organizations, such as the 
ASCO. As the AYAO working group discussed the need to engage the greater oncology 
community in oncofertility, a session of the National Physicians Cooperative addressed 
ways to communicate to and within the reproductive community (Waimey, 2013).  
In 2018, the National Comprehensive Cancer Network (NCCN) published 
guidelines for Adolescent and Young Adults (AYA) Oncology that focuses on treatment 
and management of cancer in the AYA group (Coccia et al., 2018). These guidelines 
suggest aspects of care for this group additional to those of adult care that includes risks 
involved in care, patient screening, diagnosis, and survivorship.  
Oncofertility Science Education  
In addition to the guidelines on FP treatment and counseling, a second group of 
scholars met to discuss the oncofertility community’s science education efforts, which 
simultaneously educates young people about oncofertility and promotes the study of 
science and medicine on the part of young students (Waimey, 2013). According to 
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Waimey (2013) the group stated that these two missions ensure that more young people 
are aware of the reproductive effects of cancer treatment and enter the pipeline to become 
the next generation of scientists and clinicians. In the past five to ten years, members of 
the Oncofertility Consortium have accomplished this by developing the Oncofertility 
National Science Education Network (ONSEN) at the four locations across the country 
mentioned above that together educate more than 250 high school students. The working 
group discussed that future ONSEN efforts will include assessment as a major goal and, 
in particular, evaluation of outcomes in a manner appropriate to the objective of the 
educational program. Such metrics can be used to inform educators developing the next 
generation of oncofertility leaders better and inform similar science education programs. 
Further, a “teach the teachers” program has been launched that allows high school 
teachers to participate in oncofertility research in a laboratory setting and develop 
curricula to implement in their classrooms (www.nubio.northwestern.edu). As the 
working group discussed, the principle advantage of this program is the ability to teach 
oncofertility to a greater number of students. Further dialogue identified the need for 
sustainability and funding to expand both programs and support new sites. Finally, 
working group participants stressed the need to ensure that these educational programs 
are integrated in existing local university and school environments to achieve 
sustainability. 
Guidelines and Clinical Practice  
Guidelines    
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The ASCO (Loren et al., 2013) introduced the guidelines first in 2006 and revised 
recommendations for healthcare providers (including medical, radiation, pediatric, and 
gynecologic oncologists, urologists, hematologists, and surgeons) to discuss FP methods 
with patients of reproductive age as early as possible in cancer treatment. This discussion 
can take place between the provider and patient or the patient’s parent/legal guardian. 
ASCO developed a set of key recommendations after a systematic literature review 
published from March 2006 through January 2013 using MEDLINE and the Cochrane 
Collaboration Library (Loren et al., 2013). These guidelines were updated in 2018 (Oktay 
et al., 2018).  
The following recommendations were made for clinical practices:  
Recommendation 1: People with cancer are interested in discussing FP. 
Healthcare providers caring for adult and pediatric patients with cancer 
(including medical, radiation, gynecologic and pediatric oncologists, 
urologists, hematologists, surgeons, and others) should address the 
possibility of infertility as early as possible before treatment starts.  
Recommendation 2: Healthcare providers should refer patients who 
express an interest in FP (and those who are ambivalent) to reproductive 
specialists. 
Recommendation 3: To preserve the full range of options, FP approaches 
should be discussed as early as possible, before treatment starts. The 
discussion can ultimately reduce distress and improve quality of life. 
Another discussion and/or referral may be necessary when the patient 
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returns for follow-up after completion of therapy and/or if pregnancy is 
being considered. The discussions should be documented in the medical 
record. (Oktay et al., 2018) 
An article on the changing perspective about improving access to FP (Cedars, 
Letourneau, Lisko, & Rosen, 2011) suggested that clinicians must become more aware of 
their patients’ desire to be mothers and about their individual reproductive potential. The 
authors suggested a collaborative approach between oncology and fertility teams to help 
patients understand their risk of treatment-related infertility better, as well as how to take 
effective measures to mitigate it. There are other clinical guidelines available from such 
organizations as the National Comprehensive Cancer Network, the International Society 
for Fertility Preservation, and the American Society of Registered Nurses. 
Clinical options for FP 
Several FP options are available for patients (Mayo clinic staff, 2014): 
• Embryo cryopreservation. In this procedure, women receive ovarian 
stimulation, and eggs are harvested from the ovaries, fertilized with sperm 
through in vitro fertilization (IVF), frozen, and stored. This method has the 
highest chance of success for women. 
• Egg freezing (oocyte cryopreservation). Similar to embryo 
cryopreservation, the patient receives injections of a medication that 
stimulates the ovaries, after which the unfertilized eggs are harvested and 
frozen. This is now an accepted practice, and has shown improved results. 
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This procedure is ideal for women who do not have a sperm donor, have 
ethical concerns, or desire reproductive autonomy.  
• Ovarian transposition (oophoropexy). This procedure is recommended for 
patients who are having pelvic radiation. The ovaries are repositioned 
surgically just before therapy so that they are as far as possible from the field 
of radiation planned. However, with scatter radiation, the procedure does not 
always protect the ovaries. After treatment, the ovaries may need to be 
repositioned again or IVF may be necessary to achieve conception. 
• Shielding. Shields placed carefully can reduce reproductive organs’ 
exposure to scatter radiation in patients who are having radiation applied to 
an area distant from the pelvis. 
• Ovarian Suppression. This is applied when drug therapy or surgery is used 
to prevent ovaries from producing the estrogen tumors require to grow. 
• Ovarian tissue cryopreservation. This is a method to preserve immature 
eggs by freezing the outer layer of the ovary for future use. When the frozen 
cells are thawed and then transplanted back to the ovary or fallopian tube, 
they can restore the ovary’s function, such that it begins to produce eggs and 
hormones.  
• Clinical studies of FP methods have indicated that shielding treatment can 
preserve fertility in some, but not all patients. Cryopreservation of ovarian 
tissue appears to be a very promising method of providing the cancer patient 
with a realistic chance of preserving fertility (Maltaris et al., 2007). 
23 
 
Current Status of Clinical Practice 
After the 2006 ASCO clinical guidelines for FP in cancer patients were issued, a 
study was conducted to identify the frequency of fertility discussions and the factors that 
influence the rate of such discussions (Kumar, Merali, & Pond, 2012). Results of the 
survey indicated that discussions about fertility risks in cancer treatment were 
inconsistent and did not occur regularly among young adults diagnosed recently. Only 
34% of patients between the ages of 20 and 40 referred for cancer treatment had a 
documented discussion regarding the fertility risks associated with treatment and the 
options available for FP. However, discussions occurred more frequently with younger 
patients and among those undergoing radiation (Kumar, Merali, & Pond, 2012). Hence, 
more initiatives, such as establishing specific protocols to facilitate FP discussions and 
developing tools to educate patients, may be needed to promote adherence to the 
guidelines. Another study addressed the comprehension of the fertility discussions that 
did occur (Balthazar, Deal, Fritz, Kondapalli, & Kim, 2012). Higher comprehension 
scores were associated with a college education, higher income, a primary diagnosis of 
breast cancer, additional contact with the FP specialist following initial FP consultation 
(FPC), and the use of specific reference websites, such as www.fertilehope.org. Parity, 
marital status, and completion of FP treatment were not associated with knowledge 
scores. FP knowledge following comprehensive FP consultation remains limited. 
Modifications to the current single-visit FPC, such as a standard follow-up visit or 
additional educational tools, may be needed to improve patients’ understanding of 
complex FP treatment options (Balthazar, Deal, Fritz, Kondapalli, & Kim, 2012). 
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A systematic review of 23 studies conducted in May 2016 concluded that despite 
the fact that clinical guidelines had been published for the last 10 years, oncofertility 
support is still not delivered to the standard of the guidelines and providers fail to provide 
the care recommended for eligible patients (Logan, Perz, Ussher, Peate, & Anazodo, 
2018).   
Patient/provider Communication Relationship 
Studies have shown that patient/provider communication has an effect on positive 
outcomes among patients (Arora, 2003). A diagnosis of cancer is a life-changing 
incident. Patients experience many emotions, including denial, anger, fear, distress, 
depression, sadness, and loneliness. From diagnosis to treatment and remission, patients 
must deal with significant uncertainty and face several decision points. Making decisions 
based on insufficient data and unknown outcomes can be extremely stressful. In addition, 
patients are dealing with the side effects of chemotherapy and/or radiation, and time is 
not always on their side. In some situations, providers have to begin treatment 
immediately, which can be overwhelming for patients. In addition to the cancer 
treatment, FP choices can complicate the situation further for the patient as well as the 
family members and spouse/partner. Patients often rely on their physicians to provide 
them with social/interpersonal, informational, and decisional support (Arora, 2003), and 
communication plays a central role in providing quality patient care. Bakker, Fitch, Gray, 
Reed, and Bennett (2000) examined interactions between women with breast cancer and 
their cancer care specialists from the patients’ perspective. Their study was conducted 
while the women underwent chemotherapy. From their narratives, several patients 
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identified professional and contextual factors that influenced their perceptions about the 
quality of their communication experience. This study described the reports of 40 women 
who shared their experiences with their healthcare providers during cancer treatment. The 
findings suggested that patients seek practical and emotional support during treatment. 
Patient Referral 
Studies have indicated that it is not only the quality of communication that is 
important to improve the patient’s overall outcome, but also that early referrals to fertility 
specialists are beneficial. One study was conducted to determine whether early referral to 
reproductive specialists improves FP outcomes and reduces the delay in adjuvant 
treatment in young women with breast cancer (Lee et al., 2006). Patients who had oocyte 
retrieval within five weeks of surgery were able to complete a second cycle within nine 
weeks. FP referral before breast surgery enabled earlier initiation of cryopreservation 
cycles and chemotherapy and, when appropriate, multiple FP cycles. Women who can 
undergo multiple cycles are at an advantage for FP, because a larger number of oocytes 
or embryos can be cryopreserved. This study indicated that early referral for FP among 
breast cancer patients most likely would have better results than when conducted later or 
post chemotherapy (Lee et al., 2006). This shows that earlier FP referrals have certain 
clinical advantages, as eggs can be harvested in multiple rounds. Thus, early referral is an 
essential intervention in FP and must be a part of FP discussions. This article suggested 
that failures in patient/provider communication that lead to later referrals can 
compromise the patient’s fertility permanently (Lee et al., 2006).  
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FP communication also depends on the patient’s ethnicity. A study that focused 
on provider/patient communication about FP among African American women with 
cancer suggested that only certain populations had the opportunity to discuss FP, and that 
there is a need to improve the number of these patients who are made aware of FP 
options. The study showed that there is a disparity among ethnicities in receiving fertility 
information (Vadaparampil, Christie, Quinn, Fleming, Stowe, & Bower, 2012). 
Spouse/partner concerns with infertility and FP options 
The effect on couple’s relationships of infertility attributable to cancer has 
received less attention from researchers. There is evidence that infertility among couples 
leads to feelings of loss of control, perceived loss of femininity or masculinity, and loss 
of attractiveness or self-esteem (Oncofertility Consortium, 2013). Infertility attributable 
to cancer treatment may produce the same feelings of loss, coupled with the stress of 
dealing with cancer. There are several decisions that couples need to make when they opt 
for FP: 
1)      Which FP method should they use? 
2)      Should the cancer treatment be delayed for FP treatment? 
3)      What legal issues are involved? 
4)      What are the ethical and religious norms of each partner that need to be 
addressed before proceeding with FP? 
5)      What should be done with preserved eggs in the case of death or divorce? 
Cancer patients have identified their partners/spouses as the partner who is used 
most often and is most helpful in fertility discussions (Tschudin, Bunting, Abraham, 
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Gallop-Evans, & Fiander, 2010). Communication between the patient and his/her 
spouse/partner increases relationship satisfaction when discussing infertility concerns 
(Woodruff, Clayman, & Waimey, 2014). According to Shen and Badr (2013), 
constructive communication increases marital satisfaction, regardless of sexual 
dysfunction and satisfaction. Cervical cancer patients who opt for FP experience 
decreased distress compared to those who do not. Because discussions with 
spouses/partners play an important role in couples’ decisions, DAs for making FP 
decisions should involve spouses/partners. 
DAs and Decision-making 
According to the International Patient Decision Aid Standards (2012), “Decision 
aids are tools designed to help people participate in decision-making about healthcare 
options. They provide information on the options and help patients clarify and 
communicate the personal value they associate with different features of the options,” 
and help patients navigate complicated medical decisions. However, they do not replace 
medical advice, nor do they favor one procedure over another. They collate information 
and provide various options that are available to patients, but the patient always makes 
the ultimate decision. An advisor or social worker or other provider can support DAs to 
help patients make choices. Many medical decisions are complex; providers may not be 
able to give one right answer to their patients, and these decisions have long-term effects 
on the patients’ quality of life. Patients may have to weigh unknown risks against 
unknown benefits, and there is no best answer to a problem. The choice a patient makes 
depends on what s/he wants in the end. DAs also help provide information to the patient 
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and improve his/her satisfaction with the decision made. Most patients are able to choose 
based on their personal preferences and life goals. However, the decision process is not 
linear. Patients must consider the advantages and disadvantages of the choices they have 
made, and DAs may be an important component in the process, together with advice from 
the healthcare provider, family, the patient navigator, and other hospital staff. 
Patient DAs may be delivered in various ways, including pen and paper or digital. 
The objective of this research was to generate data on the roles of a patient’s 
spouse/partner that may inform development of internet-based DAs for cancer patients. 
The current definition of delivering patient DAs on the internet is the “…process of using 
the Internet to provide some or all components of a patient decision aid to help 
individuals (e.g., patients, caregivers, proxy decision makers, etc.) involved in the process 
of choosing between two or more medically appropriate healthcare options (e.g., 
preference-sensitive care)” (Hoffman et al., 2013). Patients may use these DAs at a 
healthcare facility or from their homes. Choosing a DA begins by collecting initial 
demographic information about the patient, followed by his/her key goals during 
treatment; it also provides options along the way. As well as helping the patient, this tool 
educates him/her about the treatment. 
Decision Aids to Help People Who Are Facing Health Treatment or Screening 
Decisions 
This study in future may inform development of DA’s that can be inclusive of 
Spouse/Partners. According to the International Patient Decision Aids Standards (IPDAS) 
Collaboration (Elwyn, 2006; IPDAS 2005a; Joseph-Williams, 2013), DAs are evidence-
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based tools designed to help patients participate in making specific and deliberated 
choices among healthcare options. Patient DAs supplement (rather than replace) 
clinicians’ counseling about options. 
There is no single best choice in many treatment and screening decisions. These 
types of decisions are considered “preference-sensitive” because there is insufficient 
evidence about outcomes or there is a need to exchange known benefits and harms 
(Stacey, 2014). Clinical Evidence (2013) classified 3000 treatments as: 50% having 
insufficient evidence; 24% likely to be beneficial; 7% requiring “trade-offs between 
benefits and harms;” 5% unlikely to be beneficial; 3% likely to be ineffective or harmful, 
and only 11% being clearly beneficial. Not only does one have to consider the strength of 
the evidence, but even for the 11% that show beneficial effects, it is necessary to translate 
the probabilistic nature of the evidence for patients to reach an informed, value-based 
decision. Patient DAs are an intervention that can be used to present such evidence 
(Brouwers, 2010). 
DAs help patients become aware of their choices, understand complex 
information, make informed choices, and increase satisfaction with decisions. Identifying 
and making a decision about the best health treatment or screening option can be difficult 
for patients. DAs can be used when there is more than one reasonable option, when no 
option has a clear advantage with respect to health outcomes, and when each option has 
benefits and harms that patients may value differently. DAs may be pamphlets, videos, or 
web-based tools (Stacy et al., 2014). They provide clarity in making decisions by listing 
all the options and helping patients understand their choices and their advantages and 
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disadvantages. They also help personalize the decision-making path and lead to making 
shared decisions with their practitioner.   
Many studies have demonstrated that DAs are an important tool in shared 
decision-making, which is defined as a process by which a healthcare choice is made by 
practitioners together with the patient (Charles, 1997) and is said to be the crux of 
patient-centered care (Weston, 2001). The four major tenets of shared decision-making 
are that: 1) it involves at least two participants; 2) both parties (physician and patient) 
take steps to participate in the process; 3) information sharing is a prerequisite, and 4) a 
treatment decision is made with which both parties agree (Charles, 1997). 
 Stacey et al. (2014) reviewed 115 studies from June 2012 to 2014 that included 
34,444 participants, and found that when patients use DAs they: “a) improve their 
knowledge of the options (high-quality evidence); b) feel more informed and more clear 
about what matters most to them (high-quality evidence); c) have more accurate 
expectations of possible benefits and harms of their options (moderate-quality evidence); 
and d) participate more in decision-making (moderate-quality evidence).” To accomplish 
this, patient DAs may describe the options in sufficient detail that clients can imagine 
what it is like to experience their physical, emotional, and social effects, and/or guide 
clients to consider which benefits and harms are most important to them (Stacy et al., 
2014). 
 DAs are more comprehensive than are the usual educational material provided to 
patients. DAs are based on principles of shared decision-making and empower patients to 
take ownership of their decisions by participating more in the decision-making process, 
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while standard educational materials help people understand their diagnosis, treatment, 
and management in general terms. DAs can be used before, during, or after a clinical 
encounter to enable patients to become active, informed participants. The ultimate goal of 
patient DAs is to improve decision-making to reach a high-quality decision.  
 Role of social workers in oncofertility decisions  
Oncology social work is the primary professional discipline that provides 
psychosocial services to patients, families, and significant others who are facing the 
effects of a potential or actual diagnosis of cancer. The scope of oncology social work 
includes clinical practice, education, advocacy, administration, policy, and research. The 
standards of practice provided in the AOSW Oncology Social Work Standard of practice 
are intended for clinical social workers practicing in the specialty of oncology social 
work (“AOSW Oncology Social Work Standards of Practice,” 2012).The scope of 
practice in oncology social work identified in the AOSW Standards of Practice includes: 
• Oncology social workers shall be knowledgeable about oncologic diseases and 
their treatments, psychosocial implications for individuals and families, 
appropriate interventions and available community and governmental resources. 
Oncology social workers must have knowledge of the usual course of cancer and 
its treatment, including genetics, so that patients and families can be helped to 
anticipate and deal with changes in individual and family life. 
• Services to cancer survivors, families, and caregivers through clinical practice 
providing comprehensive psychosocial services and programs through all phases 
of the cancer experience, including knowledge about cancer and its treatment, 
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including level of understanding, characteristics of the patient’s support system, 
patient and family psychosocial functioning, including strengths, limitations and 
coping skills, race, ethnicity, religion, culture, language, physical or mental 
disability, socioeconomic status, sexual orientation, and gender identity or 
expression, and identification of barriers to care.  
• Services to institutions and agencies to increase their knowledge of the 
psychosocial, social, cultural, and spiritual factors that affect coping with cancer 
and its effects, and to ensure provision of quality psychosocial programs and care.  
• Services to the community through education, consultation, research, and 
volunteering to use, promote, or strengthen the community services, programs, 
and resources available to meet cancer survivors’ needs. 
• Services to the profession to support the appropriate orientation, supervision, and 
evaluation of clinical social workers in oncology; participate in and promote 
student training and professional education in oncology social work, and advance 
knowledge through clinical and other research. (“What Are Social Workers’ 
Roles in Oncofertility?”, 2015)  
A study by King et al. (2008) found that social workers typically do not discuss 
FP methods with patients; however, they may be in an ideal position to facilitate the 
conversation between the physician and patient. There is a strong need to develop 
educational interventions that target oncology social workers to help facilitate discussions 
with patients. Oncofertility consultation falls within the scope of oncological social work. 
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This study will help oncological social workers provide knowledge that may be applied 





Chapter 3: Theoretical Framework 
This research focused on couples’ FP decision-making process. The study was 
grounded in the recognition and understanding of power/influence dynamics among 
couples making a decision. The way one partner influences the other’s decision can 
provide insight into the entire decision-making process. Behavior exchange theory is a 
key theoretical framework that addresses this process among couples. 
Behavior Exchange Theory 
This theory elucidates the decision-making process of couples in various kinds of 
relationships. Behavior exchange theory (BET) proposes that social behavior and 
couples’ decision-making is the result of an exchange process (John et al., 1976), the 
purpose of which is to maximize benefits and minimize costs. According to this theory, 
people weigh the potential benefits and risks in social relationships. When the risks 
outweigh the rewards, people terminate or abandon a relationship. This framework may 
be helpful in understanding the exchanges negotiated between couples that lead them to 
make the complicated decision to engage in FP. According to BET, couples weigh the 
potential benefits and risks of a decision together, and their decisions are based upon their 
mutual and complementary goals. Resource theory, an extension of BET, states that the 
partner who has more resources will have more power in decision-making. According to 
this theory, an individual’s personal resources relative to those of others are the basis of 
that power. Relative income, education, time available, and social status are examples of 
factors that contribute to power (Belch, 2002). This theory will help us understand who 
has the greater say in making a decision. 
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Social Power Theory 
Social power theory (SPT) is another theory to consider. According to Raven, 
Centers, and Rodrigues (1975), there are six bases of conjugal power from the 
perspective of social power (Belch, 2002). Social power is “…the potential influence of 
one person over another” (Cartwright & Zander in Swasy, 1979, p. 316). Thus, power is 
the total possible change that one social agent can cause in another’s attitude, behavior, 
and beliefs (Swasy, 1979). The six bases of conjugal power are: reward; coercive; 
referent; legitimate; expert, and information power, and this theory is used to understand 
the way one partner in a couple may influence the decision of another.  
Expert power—the belief that one family member has superior knowledge or 
ability that will result in the best outcome possible—was found to be particularly relevant 
to family decision-making. The attribution of expert power was shown to increase with 
education and social class and with more syncretic decision-making (Belch, 2002). This 
facet of the theory may apply in this situation, as the male spouse may consider that his 
partner is the best person to make the decision, as having and raising children primarily 
are her responsibilities. 
However, one cannot rule out such other bases as coercive or reward power, 
which means that one may either punish or reward the other person while making FP 
decisions. Information power stems from logic and reasoning and the importance of 
knowledge and communication. The roles of the provider, DAs, and other information 
factors may influence couples’ decision-making. This may be followed and influenced by 
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expert power when one couple or, in the case of FP decision-making, the “provider,” may 
be considered an expert. 
Theory of Planned Behavior 
Another theory that may predict health behavior is the theory of planned behavior 
(TPB), which has been used widely to predict and explain a range of health behaviors and 
intentions, including health services use, among others. TPB states that behavioral 
achievement depends on both motivation (intention) and ability (behavioral control). The 
three components of the theory, attitude, subjective norms, and perceived control, may 
predict such patient fertility intentions as having one, two or three children, having 
children after a certain age, or having children with a partner (Ajzen & Klobas, 2013). 
For example, attitude can be measured by such behavioral beliefs as “I want to have a 
child, as it is fulfilling or would please my partner.” Subjective norms may influence 
fertility, e.g., “My parents or in-laws want me to have children” (Ajzen & Klobas, 2013). 
To a greater extent, attitude is a person’s internal choice, while subjective norms are 
attributable to external influences and pressures. Perceived control beliefs are concerned 
with resources and obstacles that can facilitate or interfere with having a child. For 
example, one may consider the importance of housing in having a child. It would be 
relevant in such a case to know how important it is to a patient to have housing before 
having a child (Ajzen & Klobas, 2013). Thus, TPB was relevant in this research. 
Theory of Attribution, Marital Satisfaction, and Dyadic Interaction 
To understand couples’ decision-making, theories of attributions and marital 
conflict were considered to develop the interview questions. The goal of the study was 
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not only to examine the couples’ overt expressions while discussing their FP decisions, 
but to understand such covert variables as beliefs about children, adoption, etc.  
 Couples’ communication exchanges depend not only upon the way a message is 
delivered to the spouse/partner, but also what attributions the receiving spouse/partner 
assigns to that communication (Bradbury & Fincham, 1990). Systematic study of the 
attributions couples assign to their communication and that of their spouses is believed to 
explain and enrich the understanding of patterns of behavior exchange that differentiate 
distressed from non-distressed couples (Bradbury & Fincham, 1990). For example: 
The common tendency in distressed marriages for a negative behavior of 
one spouse (“You really should be more pleasant around my parents”) to 
be followed by a negative behavior by the partner (“Don’t tell me how to 
behave!”) may be due to the attribution that the partner makes for the 
spouse’s behavior (“He bosses me around because he doesn’t care about 
me or my feelings”). (Bradbury & Fincham, 1990, p. 3) 
 To understand the relation between attributions and marital decisions better 
requires consideration of the behaviors that spouses exhibit and the attributions they 
assign during interactions. Explicit consideration of overt behavior in relation to 
attributions and marital decision-making may be justified and explained further by its 
potential to understand attribution and marital communication in a dyadic communication 
study. 
Borrowing the basic concepts of this theory, this study designed the interview to 
accommodate dyadic interactions through couple interviews, including questions that 
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explored what spouses attribute to patients’ feelings. For example, one of the questions 
included in the research was, “How important is it to you that your partner be able to 
have her own biological child in the future?” 
 These theories explain the decision-making process among couples and provide a 
basic framework; however, their applicability in such a medical decision as FP is 
unknown. Factors that include unknown risks, an uncertain future, and family and 
cultural pressures may change the way a couple interacts and makes decisions about FP. 
The Ottawa Decision Support Framework (ODSF) is a theoretical framework that may 
help explain processes and contributing factors involved in spousal interactions fully, the 
various characteristics that lead to a decision, and reflections after a decision is made.  
The Ottawa Decision Support Framework 
The ODSF and underlying decision-making theories in psychology, behavioral 
science, and economics formed the conceptual framework for this study. The ODSF is an 
evidence-based, practical, mid-range theory to guide patients as they make health or 
social decisions. It uses a three-step process to: 
1. Assess client and practitioner determinants of decisions to identify decision 
support needs 
2. Provide decision support tailored to client needs using counseling, decision tools 
(patient DAs, guides), and decision coaching 
3. Evaluate the decision-making process and outcomes 
The framework is based on concepts from general psychology (Tversky & 
Kahneman, 1981), social psychology (Ajzen & Fishbein, 1980), decision analysis 
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(Keeney & Raiffa, 1976), decisional conflict (Janis & Mann, 1977), social support 
(Norbeck, 1988; Orem, 1995), and economic concepts of expectations and values 
(Feather, 1980), all of which it applies to provide a framework to explain the complicated 
process of making healthcare decisions.  
The ODSF framework can be used as a guideline to study couples’ decision 
conflicts by examining the support they receive and their satisfaction with the decision. 
These tenets guided the research study. Findings from previous literature suggested that 
this framework has been used in the past to study other medical decision-making (Légaré 




The original framework includes the following points: 
(Figure 1 at page 91) 
 
The framework in Figure 1 provides a process that facilitates shared decision-making. It 
describes key concepts and was adapted from the ODSF. 
 Couple decision-making is part of shared decision-making, and this model 
informed and was adapted for this study. 
This theoretical framework will help facilitate understanding of the following areas: 
1. Couples’ process of making FP decisions  
2. Effect of marriage/partnership on the way couples cope with infertility problems 
and treatment 
3. Spouse/partner involvement in the entire process of oncofertility consultation 
4.  Couple’s ethical and legal concerns about FP  
The ODSF may help couples traverse a structured process of shared decision-
making. The ODSF helps identify decisional conflict, which is one of the key elements in 
making decisions (Légaré et al., 2006). Decisional conflict can be described as a state of 
uncertainty about which course of action to take when the choice among competing 
actions involves risk, loss, regret, or a challenge to personal life values (Carpenito-Moyet, 
2006). This study investigated couples’ characteristic views on the types of difficult 
decisions patients face, the factors that make those decisions difficult for couples, the 





Chapter 4: Research Questions and Methods 
Research Questions 
This study was designed to explore the FP decision-making process from a 
heterosexual couple’s perspective, and the roles of spouses/partners in decision-making 
by examining specifically their attitudes, behaviors, beliefs, strategies, and the support 
they seek and provide to patients during FP decision-making. The goal was to gather data 
about their perceptions and experiences while making shared decisions with their 
spouses/partners to obtain a deeper theoretical understanding of which elements are 
important in addressing FP decision-making and help identify which 
strategies/approaches are effective in supporting couples throughout the process. Thus, 
the following research questions were investigated: 
1)    What is the effect on spouses and conjugal life of potential infertility among young 
patients with cancer? 
2)    How do heterosexual couples reach FP decisions? 
3)    How does being in a marriage/partnership affect the way they cope with infertility 
problems and treatment? 
4)    How can spouses/partners be involved in the entire process of oncofertility 
consultation? 
5)    What are spouses’/partners’ ethical and legal concerns about FP? 
6)    What recommendations do couples have for those going through similar situations 






 Grounded theory is “the discovery of theory from data” (Glaser & Strauss, 1967). 
Theory develops from meanings, actions, stories, and the lived experiences the data 
reveal. Grounded theory does not begin with a theory or hypothesis and is not designed to 
prove anything right or wrong. It begins in an area of research and considers data as they 
emerge (Merriam, 2002). Grounded theory sees beyond research and empirical processes 
and delves into the data deeply to “portray a picture of [the] whole” (Charmaz, 2006).  
Grounded theory is a useful method when there is little or no knowledge available 
in a particular area, and few studies have explored the effects of potential infertility when 
one partner has cancer. This study investigated the unique experiences of the 
spouses/partners of those who are undergoing cancer treatment and may experience 
infertility. The theory also is useful when attempting to understand the way people define 
and experience situations within a particular context.  
 Grounded theory is assessed by fit, understanding (workability), generality, and 
modification (Glaser & Strauss, 1967). A theory’s fitness means that it should correspond 
to the place or field in which it will be used. According to the workability or 
understanding standard, laypersons should be able to understand the theory. The 
generality assessment seeks to ensure that the theory is sufficiently general to apply to 
more than just one specific situation. Finally, modification is assessed by the ability to be 
flexible in altering or changing the theory as situations change over time (Glaser & 
Strauss, 1967). This exploratory study used grounded theory to examine the roles and 
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experiences of the spouses/partners of patients undergoing cancer treatment in making FP 
decisions, the way potential infertility affects a couple’s relationship, and the way 
healthcare providers can support the couple in making shared decisions. The results of the 
study were compared to existing theories in the field of couple decision-making.  
Although theory is emergent and derives from the data (Crotty, 1998) in grounded 
theory, the theory is open to the results of other empirical studies. The ODSF is an 
established framework in the literature that addresses decisional conflict. The themes 
about couples’ FP decisions emerged from the data themselves and were incorporated in 
the ODSF. This was attempted considering the audience and purpose of the research. 
ODSF is an established framework used when constructing DAs and educational 
material. This study attempted to test the themes that evolved and whether they fit the 
framework. According to Charmaz (2006) “One might stumble upon a theoretical 
framework and can use it to provide an anchor to the reader and to demonstrate how your 
grounded theory, refines, extends, challenges or supersedes extant concepts.” This 
framework was used in post-facto data collection during data analysis.  
 Credibility includes appropriate familiarity with the data, becoming familiar with 
other comparison groups, and providing evidence for claims the researcher makes. 
Originality refers to data that provide new insight about their meaning or challenges that 
exist already. Resonance refers to a researcher’s posture of openness and receptivity to 
the potential meanings embedded in text. I used resonance in this study by associating 
couples’ general decision-making to their specific FP decision-making process. 
Usefulness indicates that data are interpreted accurately, implications are offered, and the 
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study contributes to understanding (Charmaz, 2005). I demonstrated usefulness by 
addressing issues of trustworthiness and rigor. 
The study used purposive sampling, individual interviews with the spouse/partner, 
and joint interviews with the spouses/partners and patients. 
Sample 
Participants were heterosexual male spouses/domestic partners of young adult 
women undergoing cancer treatment at MD Anderson Cancer Research Center who were 
at risk for infertility related to cancer. Spouses were defined as legally married couples, 
while partners were defined as two adults living together. The inclusion criteria for a 
domestic partnership included: 
• 18 years or older 
• Unrelated biologically 
• Living together 
• Not currently in a domestic partnership, civil union, or marriage with a 
different person 
• Mutually responsible (fiscally and legally) for each other 
• In an intimate, committed relationship of at least six months’ duration 
Sampling and Recruitment 
This study used purposive sampling to recruit domestic partners of patients 
undergoing cancer treatment who agreed to be interviewed for the study. The total sample 
was 24 individuals. 12 couples were interviewed together and their spouses/partners were 
interviewed separately thereafter. This study investigated a broad range of the 
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experiences of spouses/domestic partners of these patients in different decision-making 
situations and related the findings to FP decision-making. The interviews included two 
parts of 45 minutes each. One was the joint interview of the patient and the 
spouse/partner and the other was with the spouse/partner alone. This dissertation was 
conducted in collaboration with MD Anderson Cancer Center to enroll participants, and 
was a subsection of a larger ongoing project. A study coordinator asked the couples who 
came in for fertility treatment if they were willing to be interviewed together. If the 
patients and their spouses/partners agreed, then they were mailed a consent letter. The 
interviews were conducted by phone so that the couples and spouses/partners could talk 
about their experiences in the comfort of their homes or offices and were scheduled at 
times convenient for them. Telephone interviews also allowed patients from out of town 
to be accommodated in this study. The study researcher explained the purpose of the 
study to participants using clear and plain language, and gave the participants the 
opportunity to ask questions. The participants were informed that they could withdraw 
from the study at any time. The study was approved by the PSU Institutional Review 
Board (IRB) and the MD Anderson Cancer Research Center IRB.  
Data Collection 
Individual interviews with the spouses/partners (see Appendix A for interview 
guide) and questionnaires were used to explore the research questions. There also was a 
conjoint interview with the patient. First, the couples were interviewed over the speaker 
phone. After the 45-minute couple interview, individual interviews were conducted with 
the spouse/partner. If the participant had questions, the researcher clarified and ensured 
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that the participant understood the questionnaire, which was administered before the 
interview began. The researcher transitioned into the semi-structured interview using 
questions developed in the interview guide, which included specific questions with 
respect to their relationship with spouses/partners, fertility issues, and the process of 
decision-making, including follow-up questions based on each participant’s responses. 
The telephone interviews were recorded with a password-protected iPhone. Data were 
transferred to a secure location, and interviews were deleted from the phone thereafter. 
Interviews were transcribed and saved in the drop box.  
Dyadic Interviews 
According to Morgan et al. (2013), dyadic interviews “…offer opportunities when 
the researcher wants both social interaction and depth, when narrative is valued, and 
when interaction in larger groups might be problematic because research participants are 
geographically distant.” Dyadic interviews help the researcher understand tacit 
knowledge and elicit data in the depth and detail available in individual interviews and, at 
the same time, provide the interaction present in focus groups while making decisions 
(Morgan et al., 2013; Polak & Green, 2016). Joint interviews are a particularly 
appropriate method for studying complex shared practices such as making health 
decisions (Polak & Green, 2016). 
 Joint interviews may appear to be like everyday conversation, but couples do put 
on a performance during interactions (Polak & Green, 2016). According to Warin et al. 
(2007), participants’ responses in the interview are shaped by the positioning of the 
interviewer in relation to the research.  
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Dyadic interviews offer shared storytelling and con-construction of their 
knowledge. Being asked about their stories from the time they were diagnosed to when 
they learned about infertility may elicit two things in couples: 1) whether they agree adds 
credibility to the story, and 2) their storytelling also may hint at the power dynamics 
between the two. Contradictions found in the stories, if any, help indicate their 
differences and may provide insight into their relationship, which on the surface may 
seem non-distressed. This also is associated with the attributions the couples may project 
to each other’s responses. Again, this is a process that may provide insight into a couple’s 
relationship and decision-making process. An important aspect that may emerge during 
dyadic interviews is the negotiation that couples go through while making decisions. 
They may challenge each other during the interview, and it is informative to observe who 
prevails. 
Dyadic interview techniques were used to combine and contrast the individual 
spouse/partner and couple interviews to obtain a better understanding of their decision-
making process (Koren, 2010). As the literature suggests that the dyadic interview 
technique is useful in generating discussion with less moderation, it helped elicit deeper 
discussions between couples. Data saturation was ensured when no new information, 
categories, or themes emerged from the data. Participants’ quotes that highlighted various 





The qualitative data were analyzed based on the methodology of grounded theory. 
The grounded theory data analysis approach helps generate themes from the data 
gathered about spouses/partners’ experiences while making fertility decisions with their 
patient partners. Through grounded theory, I attempted to develop a theme that 
represented spouses/partners’ experiences, including joint family planning with the 
patient, financial decisions about treatment, and preferences and wishes while making FP 
decisions. By using grounded theory, an attempt was made to understand 
spouses/partners’ varying experiences in making FP decisions based on different 
relationship statuses, individual styles, and relevant issues. The participants were 
encouraged to tell their stories regarding the diagnosis and how they were making 
fertility decisions. Findings from this research will be instrumental in providing an 
understanding of the spouses/partners’ experiences during the FP decision-making 
process, as well as in developing standards of practice and policy within the healthcare 
system and clinical practice. NVIVO software was used to analyze data. 
Steps in data analysis 
Techniques developed by Strauss and Corbin (1990) were used to analyze the 
data: 
1) First, five interviews were transcribed and analyzed to prepare a codebook 
2) After the first five interviews, additional codes were added as reflected by the 
data 
3) Theoretical memos were written and open coded as data were collected  
4) Themes were developed 
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5) Themes were mapped visually  
6) A literature search was performed post facto to understand similar models 
7) Themes were arranged in the ODSF  
Establishing the Credibility of Research 
The research results and themes were discussed with a clinician, psychologist, and 
another researcher involved in the larger study. Peer debriefing also was conducted to 
establish the credibility of the research. Debriefing was conducted with those who are 
working directly in the field of oncofertility in the capacity of onco-gynecologists or 
psychologists/researchers and are in contact with patients engaged in FP decision-
making. The results were shared with these researchers and their feedback was discussed. 
Because the researchers were involved closely with patient interviews and developing 
DAs for patients, they have expertise in the area.  
The second method used was triangulation. The qualitative data from patient 
interviews were compared to those from the couple interviews. Although patients 
interviewed in couple interviews differed from those interviewed for the individual 
patient study, the emergent themes did indicate similar results with respect to patients’ 
values and preferences in the larger study (Woodard et al., 2017). For example, both 
studies indicated patients’ desire for biological children, concern for their future health,  
starting treatment, and ethical and moral dilemmas.  
Researcher’s Position 
I am the spouse of a cancer patient in remission and also have worked with cancer 
patients in my previous research. Further, I am aware that being the spouse of a cancer 
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patient in remission may provide an “insider’s” perspective. However, infertility 
attributable to cancer was an area of exploration completely new to me. I compared 
couple interviews with individual spouse interviews to establish the reliability of the 
findings. Moreover, the findings were compared to other research performed in the field 
to establish credibility, and I used a journal to document my thoughts and reflections 
throughout the research process.  
I received background information about the couples from their fertility clinics, 
and in most cases was aware of their type of cancer, age, and relationship status. This 
initial information about the couple helped begin the conversation with them. I opened 
most of the interviews by explaining the purpose of the study and disclosing my status as 
the spouse of a cancer survivor to make them comfortable and ease them into the 
conversation. Most interviews began with easy to understand questions about 




Chapter 5: Results 
Twelve couples were interviewed first together, after which the spouse/partner 
was interviewed separately. Couples included both married and cohabitating couples. At 
the time of the interview, the couples had participated in at least one fertility consultation 
and had been to a FP clinic. These couples were contacted through the fertility clinic to 
participate in the study.  
The paragraphs below provide general descriptions of the couples from the data 
collected in the initial demographic questions, which are shown in Table 1. Visual 
relation of the themes are shown in Figure 2. 
(Table 1 at page 88 and Figure 2 at page 92) 
Couples’ Descriptions 
Couple 1 
This is a Caucasian Christian couple in their early 30s with a 2-year-old child. 
They are married and living together, and were in their relationship when the woman was 
diagnosed with cancer. Both hold bachelor’s degrees. They did not have a fertility 
consultation when first diagnosed, but did so at a later stage. They described their relation 
as not stressed and indicated that they want to have 2-4 children.  
Couple 2 
This is a Caucasian couple in their mid-30s with one 2-year-old child. They were 
married and living together when the woman was diagnosed with cancer. The wife has a 
bachelor’s degree and the husband an MBA degree. They want to have 3-4 children 
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together. They described their relationship as not stressed and stronger because of what 
they have gone through together. 
Couple 3  
This is a nondenominational Christian, Hispanic couple. The wife is obtaining a 
master’s degree and the husband a bachelor’s degree. They were in their mid-30s and 
were married when the wife was diagnosed with cancer. Their first fertility consultation 
took place 3 years after the diagnosis when the couple was trying to conceive. The wife 
was pregnant when they first went for the consultation but did not know it, and the 
pregnancy had to be terminated because it was ectopic. The husband has a daughter from 
a previous relationship and they have no biological children together. 
Couple 4 
This is a Caucasian, Protestant Christian couple in their early to mid-40s. They 
are married and living together. At the time of the interview, the wife was expecting their 
first child. They want to have another child, but because of the wife’s age, the husband 
thinks they may adopt. Both have an associate’s degree. 
Couple 5 
This is a Caucasian, Unitarian Christian couple in their early to mid-40s. They 
both have doctoral degrees and are married. They have one biological child together. 
They want to have one more child, but because of cancer treatment, feel it is safer not to 




This is an African American couple in their early 30s. The man is an atheist and 
the woman undecided. Both have Juris doctoral degrees. They now live in two different 
cities and are unmarried but are in a relationship, and were in relationship when she was 
diagnosed with cancer. The woman had the first fertility consultation alone. The couple is 
in a non-stressed relationship and they are undecided whether they want to have children 
together in future.  
Couple 7 
This is a Caucasian, Christian couple in their mid to late 30s. They are in a 
relationship but unmarried. They do not have any children but would like to in future. 
They both have bachelor’s degrees and define their relationship as non-stressed.  
Couple 8 
 This couple is one in which the woman is in her late 20s and the man in his early 
30s. They are unmarried and live together. The woman is an Hispanic Catholic and the 
man a Caucasian Presbyterian. The woman is working toward her master’s degree and 
the man has a bachelor’s degree. Their relationship is non-stressed. The woman would 
like to have 3 children and the man 2-3 children. They have no children now.  
Couple 9 
This is a Caucasian, Christian couple in their late 20s. They both have bachelor’s 
degrees. They are married and live together. They have an 8-month-old daughter and 




This couple is in their mid to late 30s. The wife is Asian and the husband 
Caucasian. Both are Christians. The wife has a bachelor’s degree and the husband has no 
college degree. They have no children together but would like to have at least two. 
Couple 11 
This is a Caucasian, Christian couple in their early to mid-30s. They are married 
and have two children together. They would like to have one more child in future. They 
have a non-stressed relationship. 
Couple 12 
This is a Caucasian, Christian couple in their early 30s. They are married and 
have bachelor’s degrees. They have no biological children together or separately. Their 
current relationship is non-stressed, but they had some stress in the early years of 
marriage. They want to have 2-3 children in future.   
Interview Findings 
The 12 qualitative interviews were coded and analyzed to address the research 
questions. The analysis included three parts. First, only the couples’ section was 
analyzed. Significant sentences and quotes were highlighted to understand the decision-
making phenomena. In the second part of the analysis, the spouses/partners’ section was 
analyzed to obtain a better understanding of what the spouse/partner was experiencing.  
The purpose of the first part of the analysis was to understand the joint decision-
making process and the way it differs from other decisions the couple has made. In the 
second part, only the spouses/partners’ section of the interview was analyzed to 
understand their viewpoints on FP.  
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In the first part of the analysis, codes were organized into the following themes: 
1) Couples’ relationship and decision-making 
2) Couples’ response to the news of potential fertility loss  
3) Couples’ general decision-making process versus FP decision-making 
4) Legal and ethical concerns 
In the second part of the analysis, only the spouses/partners’ sections were analyzed 
and compared: 
1) Spouses/partners’ reactions to infertility  
2) Spouses/partners’ views about biological children 
3) Spouses/partners’ concerns  
4) Support 
5) Recommendations for couples in a similar situation 
The third part of the analysis entailed comparing both sections of the interviews and 
looking for shared storytelling:  
1)  Confirmation/collaboration within couples 
2)  Contradictions or differences in narrations 
3)  Differences in spouses’ versus couples’ narrations  
Couples’ Section 
Couples’ relationship and decision-making   
 Couples differed in their opinions about what was most important to them in 
making decisions in their relationship. Couples 3, 11, and 12 reported mutual satisfaction, 
couple 10 indicated willingness to compromise, couple 9 stated mutual agreement and 
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communication, couple 8 reported communication and analyzing pros and cons, couple 7 
emphasized shared communication, couple 6 indicated mutual satisfaction and fairness 
without compromising values, couple 5 reported decisions with no regrets and from 
which no one walks away, couple 4 stated that it should fit the larger goals as a couple 
and person, couple 2 indicated logical decisions with fewer risks, and couple 1 reported 
that decisions should be in favor of who feels more strongly about them. Hence, couples 
decision-making priorities differed. The most common was mutual satisfaction, in which 
both were in some way comfortable with the decision. Communication during decision-
making was important for the couples. Some mentioned making a list of pros and cons, 
while others mentioned going on dinner dates to discuss important decisions.  
Couple 3 
Patient: “I think mutual satisfaction. Not only does that fall in line with 
communication amongst each other as well. As long as we communicate and agree. Even 
if we disagree we are able to come to a final resolution that makes both of us happy. If it 
makes one happier than the other, then that is fine with the both of us.” 
Spouse: “I think for me it is more important that we both are okay with the 
decision in the end, that neither of us has any regrets about the decision.” 
Patient: “Sure, I don't want either of us to walk away from a decision, especially 
a very important decision, having any regrets about our decision process or the outcome 
of the decision.” 
The Spouse in couple 4 stated that, “One is we are going to know what we are 
talking about and how does it fit into our goals, our personal goals.” 
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Couples’ Response to the News of Potential Fertility Loss 
Women and men reacted differently to potential infertility. For example, one of 
the patients during a couple interview shared that she felt more deeply about the issue of 
not having children than her spouse did.  
Couple 4  
Patient: “He was okay without them (children), and at that point I still wasn’t 
okay without them. I felt that I wasn’t going to get to be a mom.” 
Spouse: “Because for me, just from my perspective and how it was, because as a 
man I was reaching my goals, doing things that caused me to be satisfied as a man. I 
didn’t think that I had to have children to feel fulfilled in life. So, I didn’t understand.” 
Some of the spouses were more concerned about their partner’s health than 
infertility, but women took more aggressive steps in obtaining fertility treatment.   
Patient 1: “Well, no, actually. At first—since I had gone through cancer and 
everything, he really did not want to do any type of fertility treatments where it would 
affect my body. He didn’t want to put any hormones or anything. He didn’t want me to 
have any struggles or health problems or anything again. I actually had to talk him into 
going and meeting with Dr. XXX. Once he talked to her, he felt much better about it.” 
One of the couples had to make a quick decision between the time of the cancer 
diagnosis and fertility treatment; hence, they felt helpless in the situation, as they did not 
have much time to process the news of infertility.  
Patient 2: “I feel we were kind of just thrown into it, similar to other medical 
decisions. Given that I was about to start chemo and they didn’t want to delay it. Again, it 
58 
 
was a very rushed decision and I think we kind of knew what we knew and didn’t know 
what we didn’t know.”  
Another woman was willing to bear more pain rather than risk infertility.  
Spouse 3: “She just didn’t want to have the kind of surgery to prevent her from 
ever having kids, no matter how much pain it put her in.” 
Hence, the data suggested that women were far more invested in pursuing FP than 
were their spouses/partners.  
Couples’ Process in Making General versus FP Decisions  
During the interview, couples were asked what is important for them in making 
decisions and the way the FP decision differed from similar and other major decisions. 
Couple 1 agreed that they let the partner for whom it is more important take the lead in 
the decision. 
Spouse 1: “Some things are more important to one or the other parties. So, if it is 
more important to me, [wife] will let me decide. If it is more important to [wife], I’ll kind 
of let her decide.” 
In couples’ fertility decisions, Spouse 1 indicated that he followed the same 
motto.  
Spouse 1: “In terms of fertility treatment itself, I kind of defaulted to [wife], I 
guess, a little bit with that because it was her body that was going through everything.”   
Couple 2 responded along similar lines that the person who is affected most by the 




Couples 3 and 6 believed in mutual satisfaction.  
Patient 3: “As long as we communicate and agree.”  
Couple 4 disagreed about the issue of FP.  
Spouse 4: “How does decision fit into our goals, our personal goals? If it is a 
major decision, how does it fit into life goals? Then from there, I would think then we 
would see and discuss how important it is to each other.” 
With respect to making the FP decision, this couple disagreed, as the husband was 
not in favor of having children after trying natural methods for seven years. The wife 
mentioned that after they visited a marriage counselor, he understood that it is a 
“woman's nature to have a child, that’s when everything turned around.” Hence, the 
couple reached a compromise after they understood each other’s life goals.  
In conclusion, couples’ FP decision-making was consistent with what they said 
was important for them in making any other decision.  
Legal and Ethical Concerns 
There were several religious concerns, including destroying preserved embryos.  
Husband 12: “I think the only thing that I was a little, religiously a little 
concerned about was that they recommended saving, if we had harvested eggs, they 
wanted to save them as embryos, because that was the most efficient way to preserve the 
eggs and the sperm. I was a little concerned that if we were lucky enough to get multiples 
of eggs, we were able to get multiple embryos, would we be able to use it. I wouldn’t have 
wanted any of them destroyed, so a little iffy about that.” 
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Husband 8: “Maybe a moral decision. I don’t know if it is totally moral, just 
maybe where we are in our lives, knowing that you would possibly make embryos that 
you would not even use and stuff like that. Maybe more for me personally.” 
Couple 4 had ethical concerns about terminating pregnancy if a child happened to 
have special needs and screening embryos for chromosomal abnormalities.  
 Spouse 4: “I think the biggest concern is a little bit personal, a little bit involved 
with our faith, is the thought of—it is one we will still face and we thought of if we were 
told we were going to have a special needs child. What decision would we make at that 
point? Would we continue with the pregnancy or would we terminate the pregnancy? 
That is a big issue. That is a big conflict. That is a big decision for us. One of the things 
that we did, once we did the fertility cycle and we had embryos that made it to the 5-day 
stage, we had them genetically tested, so that any abnormalities in the chromosomes, 
anything that might cause the embryo not to be a perfect embryo, we could do that pre-
screening, so those embryos that would be questionable, we would not attempt to implant. 
That was a big decision, a big discussion that we had.” 
Spouse/Partner Section 
Spouse’s/partner’s reactions to infertility 
Some spouses/partners showed more concern about the patient’s health than they 
did about expressing their emotions/reactions to infertility news.  
Spouse 1: “I guess at the time I was really more focused on just her surviving, 
making it through the chemo. The chemo treatments were really hard on her. So, it was 
more just wanting to get through. I just focused on what is front of you right now, which 
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was get through the chemo treatments, get through beating this portion and then we will 
worry about the rest of it later.” 
Spouse 3 expressed shock about the news of infertility, but again showed concern 
about the patient’s health. 
Spouse 3: “When I found out about it, it was a shock, but I was more concerned, 
once again, about her health and her mental stability, because I just know that is 
something that can devastate a woman, and a man, too.” 
For Spouse 4, the news of infertility did not matter much but, as it mattered to the 
patient, he was willing to go through fertility treatment.  
Spouse 4: “Like I said, for me I think I would have been okay without having kids, 
but the thought of not being able to give her what she desired, to fulfill her dreams, was 
deeply frustrating and deeply hurtful.”  
Spouse 5 did not view the news as a huge shock.  
Spouse 5: “This was not a huge surprise or shocker or concern for us, because, 
again, it is completely dwarfed by the medical issue. So, there was an acknowledgement 
but not a lot of emotionality about it. Again, as [wife] said, we weren’t planning to have 
any more kids anyway.” 
Spouse 7 indicated that although they were prepared for the news of infertility, 
they were not totally ready for it. 
Spouse 7: “I felt bad for her because she wouldn’t be able to do it, but we knew 
that there was a chance that she would have that for a while. We were probably a little 
prepared for it, but not fully.” 
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Largely, the spouses/partners’ reactions to infertility were followed by concern 
for the patients’ health.  
Spouse/partners’ view about biological children 
When asked how important it is to have biological children, most of the spouses 
responded that it is very important for them. 
Spouse 2: “I think very important. It is important enough that I would kind of do 
anything to try for that. If that wasn’t possible, I would be comfortable with alternatives, 
but wanted to do what we could to have a biological child that was mine.” 
However, they expressed the intensity of their desire to have biological children 
differently depending on their individual situations. For example, if the choice was 
between the patient’s health and having children, the spouses/partners stated that the 
patient’s health was the priority.  
Spouse 3: “Yeah, I would love to. It is important to me, too, but on the same 
token—this is something that basically humbles me, I’m just not wanting to put her in 
harm’s way just for that need. It is important to me, but I just don’t want to sacrifice her 
for that.” 
Spouses/partners expressed the desire for biological children for family 
connection, acceptance, and family lineage, and to have children who might have the 
same talents as the couple.  




Spouse 7: “Probably much lower on the scale (importance of having children to 
him than his partner). I am pretty indifferent about it.  
Spouse/partner concerns  
Spouses/partners expressed several concerns about making the FP decision. 
Spouse 2 felt that thinking of different scenarios while making FP decisions was 
depressing. 
Spouse 2: “I think the specific ones are kind of being thrown in this situation and 
now—as I said it was happening very quickly and not really thinking about it, and then 
all of a sudden being asked the question of, what if one of us dies in some months and you 
are left with these embryos? Who gets them? What happens if we have a gestational 
carrier carrying our child and both of us pass away—the depressing scenarios to think 
about, but certainly forced some interesting—it just required us to think through some 
things that we really never anticipated and certainly never previously talked about.” 
Spouse 5 voiced concern about the patient’s health rather than FP treatment.  
Spouse 5: “Really, the factor that I think you are getting at would be any delay in 
treatment for [patient] might mean that she is in our lives for that many days fewer. That 
was just not okay.” 
Cost as a concern came up once in the interview with Couple 7.  




Spouses/partners were asked if they felt they were supported well during the 
process, and their responses to this question depended on the couples’ individual 
experiences.  
Spouse 1 felt supported by the healthcare providers. 
Spouse 1: “Yes, we went through—yes, we went with Dr. XXX and she really laid 
out what the plans were. I made as many of the hospital visits or doctor’s appointments. 
She had ultrasounds. I made as many of them as I could. Although the focus was always 
on her, I was always asked if I had any questions or if I had any concerns.” 
Similarly, Spouse 3 felt supported well.  
Spouse 3: “Everybody that we have met, they have done a fantastic job. I don’t 
want to say this to make it sound like they didn’t do this, but just the most important thing 
I would suggest is that they just provide the most information about the processes, what 
the spouse is going through, what the possibilities, the risk factors—information, 
information, information. Just provide the most information about whatever they feel that 
need—whatever the discussion, just go into depth on everything, to where they just 
disclose everything.” 
Spouse 8: “I think they took care of us very well. They gave us plenty of 
information, and I like that we had a lot of options. I think they did a very good job.” 
 Spouse 2 related a different experience. 
Spouse 2: “I can’t think of a certain situation where I felt that I needed 
independence from [C] supports or different information. I think it would just be the 
general comment that they just seemed very unaware of the specifics of our unique 
65 
 
situation. It is not often you go to a medical provider and get a sense that they don’t know 
what they are doing, but we had that sense quite a bit going through that, which was a 
frustrating circumstance.” 
Spouse 7 had similar views. 
Spouse 7: “I don't know what support and information that she got, but I didn’t 
really get much at all. I would say if I was the average person, probably no.” 
Recommendations for couples in a similar situation 
Spouses/partners had recommendations for other couples. Spouse 1 addressed the 
importance of understanding what the patient is going through. 
Spouse 1: “I know it was very difficult for her. I guess maybe remind spouses to 
understand what they are going through, from a hormonal standpoint. My wife put a lot 
of pressure on herself to have a biological baby.” 
Spouse 2 addressed the important issue of oncologists’ lack of initiative and 
interest in discussing fertility. 
Spouse 2: “I think of the oncologist never being comfortable making a statement 
to the effect of it’s fine for you to go through this fertility treatment. I think from the 
oncologist’s perspective, there was never any good that could come of it, only harm, and 
very little understanding of how do you weigh the potential risks with the benefit of being 
able to preserve your fertility with the patients and debating with oncologist may be 




Spouse 5 said that it is important to have a fertility consultation regardless of the 
outcome.   
Spouse 5: “I think we are both pretty grateful that we went through and had that 
conversation with experts, even though the outcome was, I think, pretty obvious before we 
ever met with them. We knew that this was the end of a type of option for us to have in 
our lives, but it was comforting to know that we would not be looking back at this and 
second guessing ourselves and we were certainly doing the right thing. It is a big 
decision, even if it is obvious.” 
Spouse 7 suggested to go ahead with FP even if there is disagreement. 
Spouse 7: “I guess I would just tell them that if they don’t agree to do it, they 
can’t undo the decision later, so it is better to probably do it now, and then have the 
contract, if you want to change your mind later or if it is just eggs, there is not a big 
change for you, because it is still just an egg like it would be in her anyway.” 
Spouse 10 suggested finding support. 
Spouse 10: “There are lots of things that a couple may not be thinking about, 
where someone who has gone through the process can share. I actually think it would be 
a terrible idea not to talk to someone who has been through the process before you 
decided to go through it yourself.” 
Couples’ Shared Storytelling  
The joint interviews with the couples offered shared storytelling about their 
diagnosis and decision-making that constructed a coherent and presentable story as a 
couple. Couples were asked to narrate stories about their critical milestones in decision-
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making. Couples co-presented the story of shared decision-making, and in the process co-
constructed their knowledge about their style of decision-making and its application to 
joint problems. The interviews were analyzed for shared experiences in decision-making 
(general and FP decisions) to understand the roles of spouses/partners with the rationale 
that significant others are central to the experience of undergoing treatment, and the 
relationship between patient and spouse/partner is an important part of analysis. The 
analysis of these interview narratives was informed by Radcliffe’s (2013) methodology 
of co-construction of illness narratives among stroke survivors and their spouses. The 
interviews were designed to look for confirmation and contradictions. The confirmations 
were studied from joint interview sessions, and contradictions were studied in 
spouse/partner interview sessions to see whether couples challenged each other’s ideas as 
they narrated their stories. Further, contradictions were studied to see whether a 
spouse/partner’s narration differed between the joint interview session and the 
spouse/partner session.  
Confirmations and collaborations in narratives 
As couples narrated their stories, they completed each other’s narrations, adding 
details and reasoning for why they did what they did.  
Spouse 1: “She was diagnosed. We didn’t have a fertility consultation when she 
was first diagnosed because they needed to start treatment straight away. They didn’t 
have time to collect eggs or anything.” 
Patient 1: “And Dr. XXX wasn’t there yet.” 
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Spouse 1: “Yes, Dr. XXX was not at MD Anderson. It wasn’t an option. We 
needed to start treatment.” 
 When asked about their decision styles, most couples agreed with each other’s 
narratives.  
Spouse 2: “I would say I am a very logical thinker when it comes to making 
decisions. If that makes sense we like to talk things through. I wouldn’t say that we 
deliberate very long in most decisions. I think we like to discuss it, make a call on what 
makes sense and has fewer potential risks around it, and then go ahead and move 
forward.” 
Patient 2: “I would say that [W] is the more logical one out of the two of us. I 
tend to be a bit more emotional, but I think it is helpful be having [W]’s rational side. 
Sometimes I just let my emotions hinder my decision-making, I think. But we sit down and 
sort of go over pros and cons and we decide, I guess, mutually.” 
Couples also agreed as they discussed the way their relationship evolved during 
decision-making.  
Patient 2: “I think for me it is just making sure that I feel supported and that I feel 
like [W] is an active part in the decision. They are big decisions and they are scary 
decisions. They are decisions that you don’t know a lot about and you don’t know the 
outcome. I think just knowing that he was on my side and that we were in it together 
again, I just felt like it almost bonded us even stronger than we were before.” 
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Spouse 2: “I think that’s right. I know that it sounds like the easy answer, but I 
think it was an emotional time, so going through that together was helpful to our 
relationship generally, being closer in a time like that.” 
Contradictions in narratives 
Some contradictions were simple and were merely about timelines as the couple 
recollected the stories about their fertility consultation, treatment, and decision-making.  
Spouse 1: “When did we first meet Dr. XXX? Two years ago?” 
Patient 1: “No, we had to wait another year. We met 3 years ago.” 
Spouse 1: “2013? It’s a while since we thought about it. We did fertility treatment 
through the whole of 2014, so 2013? I think 2013.” 
 The exchange above might seem insignificant, but contradictions helped construct 
more accurate stories and reveal stages in decision-making that one partner may have 
skipped. In the following example, the patient revisited the timeline and revealed that her 
spouse did not agree with the FP procedure at first.  
Spouse 1: “In terms of fertility treatment itself, I kind of defaulted to [R], I guess, 
a little bit with that because it was her body that was going through everything. I’m 
trying to think back.” 
Patient 1: “Well, no, actually. At first, since I had gone through cancer and 
everything, he really did not want to do any type of fertility treatments where it would 
affect my body. He didn’t want to put any hormones or anything. He didn’t want me to 
have any struggles or health problems or anything again.” 
Narrative differences: Joint versus spouse/partner interviews 
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Spouse 1 expressed his concern for the patient’s health and a desire for children in 
the couple interview, but during the individual interview he indicated more strongly that  
he cared much less about having biological children and more about them staying 
together as a couple.  
Spouse 1, individual interview: “Yeah, I’ve always wanted to be a dad. I’ve 
always loved kids, but I think it was less important for me that they were my biological 
children. It is one of the things I said, when she said, you can leave me, I may never be 
able to have children. We’ll have children together. It may not be our biological even if 
we have to adopt, whatever, it is fine.”  
This is what he said during the joint interview: 
Spouse 1: “Yeah, because it was going to be her body going through all of it. I 
said, ‘Look, I’ll support and do whatever I need to on my side, but it is ultimately your 
body that is going to be going through all of this, going through all of it, and having the 
hormones. So, it is up to you. I’ll support you and we will do what we need to do.” 
Spouses/partners also disclosed some information during the individual interviews 
that they did not at couple interviews. For example, one of the spouses disclosed the 
patient’s desire and fertility challenges even before they underwent the entire cancer 
treatment.  
Spouse 1: “Very important. Yeah, it was really important for her (to have 
children). She has always wanted to be a mom. She loves babies and stuff, like most 
people do. Yeah, for her, she had always been concerned, even before the cancer. She 
only had one ovary so she was always concerned that there may be some problems with 
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her having children. It was one of the most important things for her, to be able to have 
babies.” 
 Spouses/partners were more expressive about their reactions to the infertility 
news.  
Spouse 2: “Yeah, when I accompanied [C] to one of her appointments, I guess 
maybe her initial appointment when she was first diagnosed, I think that while I had 
prepared myself that she likely had breast cancer, I don’t think I ever realized that that 
would potentially have repercussions on fertility or starting a family. It never really 
crossed my mind that that was one of the consequences of going through cancer 
treatment and chemo. I think when the doctor made a comment, and it was probably even 
kind of an offhand comment she was focused so much on the cancer diagnosis, I think she 
just casually said, this probably will mean you won’t be able to carry your own children. 
I think that was a shock to me because I had never, as I said, even thought about that. 
So, at first when the comment was made, I didn’t even realize that there were potential 
options that we could explore. I don’t think in that first meeting that was ever discussed 
in any detail. As I said, I think it was just a very quick comment and we were already so 
taken aback by everything else that was going on, we didn’t ask questions around that 
point. It was definitely a very, it is a difficult thing to kind of take when you are going 
into something not even expecting that is a potential outcome.” 
In another case, a spouse opened up during the individual interview:  
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Spouse 4: “Like I said, for me I think I would have been okay without having kids, 
but the thought of not being able to give her what she desired, to fulfill her dreams was 




Chapter 6: Discussion 
Overview of the Study 
 The objective of this study was to explore the roles of spouses/partners in making 
decisions about FP to inform the development of interventions such as educational 
material, counselling sessions, DAs, and coordination of care plans that may help couples 
make informed choices. The discussion explores the way the theoretical framework and 
results from the study answered the research question. The first section (couple 
interviews) was conducted to answer the research questions about infertility’s effects on 
couples and conjugal life, i.e., how do couples reach a decision and how do they cope 
with infertility problems and treatment in their relationship? The second section 
(spouse/partner interviews) answered the next three research questions: How can 
spouses/partners be more involved in decision-making, what are the spouses’/partners’ 
ethical and legal concerns about FP, and what are their recommendations for couples 
going through similar situations?   
Couples’ Responses to the News of Potential Fertility Loss and Coping Mechanisms 
To understand the response to infertility news, spouses/partners were asked to tell 
the story about when they first learned about fertility compromise and the way they felt. 
To achieve a deeper understanding of the way spouses/partners truly felt about infertility, 
they were asked how important they felt it was to them to have biological children.  
In the joint interview, questions related to making FP decisions were answered 
with their stories, feelings, and emotional struggles about not having children.  
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The results indicated that couples felt a sense of loss when they hear the news of 
infertility. These results were consistent with other studies that have shown that infertility 
among couples leads to feelings of loss of control, perceived loss of femininity or 
masculinity, and loss of attractiveness or self-esteem (Oncofertility Consortium, 2013; 
Schwartz et al., 2010).  
Spouses/partners of patients acknowledged the importance of having biological 
children and several expressed the reasons they wanted to have biological children 
clearly, e.g. family lineage, passing genes, etc. However, for them, the patient’s health 
took precedence over fertility treatment and they were willing to explore other options. 
Another large longitudinal study indicated that, in addition to infertility itself, the 
treatment causes additional distress (Greil, Quillan, Shreffler, 2011). Distress from 
treatments may explain spouses’ concerns and prioritizing multiple treatments (cancer 
and fertility).  
Patients (wives/female partners) were more vocal about how eager they were to 
have children of their own and their willingness to take aggressive steps to have 
biological children and pursue FP treatments. Although both patients and spouses are 
affected by potential loss of fertility, their responses differ. A study of 449 couples in a 
fertility clinic found that infertile women showed higher levels of distress on a global 
measure of psychiatric symptoms than did their partners. Women showed more anxiety, 
depression, hostility, cognitive disturbances, increased stress, and lower self-esteem 
(Wright et al., 1991). Greater distress attributable to infertility may explain patients’ 
willingness to take more aggressive steps in FP than their spouses.  
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Roles of Spouses/partners in FP Decisions 
How do couples reach FP decisions? 
Two aspects of couples were studied to understand spouses/partners’ roles in 
making FP decisions: 1) What is the status of their current relationship? 2) What is the 
couple’s decision-making process?  
To address the first aspect, couples were asked if they considered their 
relationship distressed or non-distressed. Because all couples answered “non-distressed” 
at the time of the interview, their current relationships of were considered happy and 
satisfied. Although this may not be sufficient to determine the actual nature of a 
relationship, it was accepted as stated by the couples. As the literature indicates that 
couples do put on a performance during interactions, it is possible that some couples may 
not have responded to this question truthfully (Polak & Green, 2016). 
To obtain a deeper understanding of spouses/partners’ roles in decision-making, 
particularly about FP, questions addressed couples’ general and FP decision-making 
processes and the results were analyzed to compare each member’s role in making the 
two decisions and what they felt was important in their decision-making processes.  
Couples were consistent about what they rated as most important in the two types 
of decision-making. For example, the husband in Couple 1 defaulted to the wife in the 
case of making the FP decision, as they shared in the interview that the person who is 
affected most takes the lead in their decision-making overall, and because FP affected the 
patient’s body most, she took the lead.  
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Most of the couples shared similar ideas, that if any decision affected one person 
the most, then that person would take the lead, which, in the case of FP, was the female 
partner/patient. Hence, in most cases, the spouses agreed that it was the patients’ 
decision, and they agreed with it. This result is consistent with SPT (Belch, 2002). Two 
bases of conjugal power mentioned in the theoretical framework, expert and information 
power, may support these results. Because patients are considered the ones who will be 
affected most by the FP procedures, they are considered to have more knowledge and 
hence the decisions are deferred to them.  
Another strategy of decision-making reported was making pros and cons list. This 
exercise can be explained by BET. According to the theory, people weigh potential 
benefits and risks to make a decision (John, et al., 1976). Couples make a decision by 
considering the benefits of FP and the risks involved, including delay in treatment, costs, 
and prognosis.  
However, one couple had differences of opinion with respect to FP decisions, but 
again, the patient was able to convince the spouse. Here, the decision-making process 
may be explained by the TPB, which includes three components: attitude, subjective 
norms, and perceived control (Ajzen & Klobas, 2013). Each partner may have different 
attitudes and subjective norms about having children. In this research, the disagreement 
stemmed from differences in life goals that led to differences in attitudes about having 
children.    
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Overall, couples decided in favor of the patient’s desire and described the process 
of decision-making as consistent with what they felt was important in their general 
decision-making process.  
Spouses’/partners’ concerns and support 
The most common concern among all the spouses/partners interviewed was the 
patient’s health versus FP treatment, in which spouses/partners showed concern about the 
fertility treatment’s effects on the patients. A longitudinal study by Greil et al. (2011) 
suggested that patients not only experience stress related to infertility, but also elevated 
stress attributable to infertility treatment itself, and spouses/partners also may experience 
stress related to such treatment. This area may be explored further to understand the 
phenomenon among spouses of increased concern about the patients’ health and relative 
concern about infertility treatment.   
 One of the spouses/partners also mentioned feeling depressed by all the decisions 
that needed to be made. Infertility and treatment for the same leads to poor psychosocial 
outcomes (Schwartz et al., 2010), and stress related to decision-making may lead to 
feelings of depression among spouses/partners.   
With respect to support they received from their providers, most spouses felt the 
providers supported them well and were satisfied with the information they received from 
them. However, some spouses did share stories of experiences in which they were not 
attended as per their expectations and had frustrating experiences. A prospective multi-
cohort study conducted with spouses of total laryngectomised cancer patients concluded 
that it is necessary to support the spouses to help them cope with psychological distress, 
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as well as develop treatment plans to accommodate spouses’ psychosocial needs (Meyer 
et al., 2015).  
Shared storytelling 
Couples co-constructed their stories as they narrated them. Because they were 
telling their stories in retrospect, there was a bit of confusion about timelines as one 
spouse/partner narrated and the other corrected. The effect of hearing the story in 
retrospect indicated that the timelines were blurred in the couples’ minds.   
Most of the couples confirmed each other’s narratives with respect to discussing 
their decision-making styles and evolving relationship while making the FP decision. 
However, the interesting findings of the research were the contradictions and differences 
in spousal narratives between the joint interviews and individual interviews.  
The reasons couples may confirm each other’s narratives and project a joint 
decision-making process may be attributed to social desirability factors to show their 
relationship in a positive light. Although they may discuss differences in their opinions, 
they confirmed that they reached agreement in the decision ultimately and weighed 
similar attributes that were important in their relationship and decision-making.  
There were few contradictions regarding timelines and the way each partner took 
a stand in the decisions, which helped check the credibility of each other’s accounts of 
events.  
Differences in narration between individual and joint interviews helped reveal 
more honest opinions about decision-making. Spouses/partners were more vocal and 
expressive about the way they truly felt as a caretaker and partner in the decision. 
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Although some spouses/partners expressed that they wanted to let the patient decide and 
would be supportive of their decision in the joint interviews, they did express their 
concerns, stress, and shock about infertility during the individual interviews. Polak and 
Green’s (2016) study, which stated that couples put on a performance during conjoint 
interviews, supported this finding. It was in the individual interviews that spouses voiced 
more intense and honest feelings about the FP decision and their desire for children. 
Ethical/Legal Concerns 
No legal concerns emerged from the data. However, couples discussed some 
ethical/moral concerns during the interviews. These included destroying unused fertilized 
eggs and making decisions to abort a child who had special needs. Concerns about 
abortion are beyond the scope of this study. However, concerns about unused fertilized 
eggs/embryos have been documented in the literature. Patients have voiced their 
dilemmas about destroying eggs. Clinics throughout the US store embryos but are 
becoming more aggressive about forcing couples to decide. Couples are given the 
following choices: Implant the frozen embryos; donate them to other couples; pay the 
high annual storage fee, or have them destroyed (Ekman, 2015). These ethical dilemmas 
need to be addressed as we make progress in this field. 
Spouses/partners’ Recommendations  
Spouses made several recommendations for the providers as well as other couples 
going through similar situations. Both emphasized the importance of understanding the 
patients and supporting them throughout the process despite the struggles that they are 
going through as a couple.  
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With respect to FP, spouses/partners highlighted the importance of having at least 
one FP consultation strongly. One spouse even recommended a FP procedure even in the 
case of disagreement. This recommendation may be an exception and can be attributed to 
the individual’s personal beliefs and experiences. None of the couples regretted FP or 
recommended foregoing consultation. They did recommend that oncologists be proactive 
and more invested in referring patients for fertility consultations. Overall, patients stated 
unanimously the importance of FP consultation and the advantages of going through the 
process.  
Decision Framework Anchored in ODSF 
The decision framework built from the current research was anchored in ODSF. 
This exercise was undertaken to understand the way current research can support and 
inform a standard decision framework in the decision-making field. Charmaz (2006) 
explained this practice and indicated that after research analysis, we may find a 
theoretical framework that current studies may refine, extend, challenge, or supersede. 
This research used the ODSF framework to diagram themes to see whether the data 
inform the ODSF framework in the context of couples’ decision-making.  
The way the components of the ODSF framework corresponded to the themes of 
this research is explained below.  
(Figure 3 at page 93) 
In Figure 3, Decision needs implies the decision to be made and the 
characteristics of the decision and decision makers. This study collected the 
characteristics of decision makers through demographic information, relationship status, 
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motivations for decisions (desire for children) and couples’ decision-making styles. 
Decision quality informs the ethical values that affect the decision and, in the end, who 
makes the final decision. The Decision support section informs the couples’ 
recommendations to support the decision-making process better. Although there are gaps 
in the current themes necessary to fill the framework completely, it informs future 
research in the effort to develop aids and support material for couples’ who are making 
FP decisions.   
 
 
Recommendations from the study 
 Couples’ Consultation 
 Couples’ consultation is vital in providing support to the patients making fertility 
preservation decisions. As the data suggests that spouses are invested in fertility health of 
the patients, and they do show remorse to the potential infertility news, it is essential for 
the providers to listen to spouses’ needs for information and emotional support. It is 
essential to build support system around the couple especially when it is a joint FP 
decision. Lack of such support may leave the spouses confused and distressed. This may 
negatively impact overall satisfaction in the FP decision making among young patients.  
Even though it may appear to be burden on the healthcare system to provide 
support to patients as well as spouses through FP decision making, it is essential from the 
providers’ perspective to know spouses’ opinion. Spouses may withhold their opinions in 
front of the patients as seen in the data. Along with couple consultation, separate spouses’ 
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consultations may openly bring out the honest intentions of the spouses. Hence when 
providers make FP treatment recommendations they are aware of the complete couple 
situation. Providers may also encourage the spouses to open discussions with the patients 
during FP decisions.  
Patient and Spouse Navigation 
 Oncology social workers also work as patient navigators in the clinics. 
Oncology social workers not only need to help patients but also their spouses while 
planning coordination of care for the patients. Patients more likely visit clinics with their 
spouses/partners. It is essential to actively involve them in the care plan as they are key 
stakeholders in patients’ care. Patients’ after treatment do feel exhausted. FP 
consultations and paper work may be overwhelming for the patients. Involving spouses 
may take some of the burden away from the patients, hence improve couples’ experience 
in clinic. 
Future studies will be needed to confirm if the above mentioned recommendations 
improve the quality of care for the young couples making FP decisions thus justifying 
time and money spent on working with the couples rather than just patients.   
Implications for Future Research 
 This study addressed a significant gap in understanding couples’ decision-making 
with respect to oncofertility. It was an exploratory study that provides various 
opportunities for future research in theory development and decision frameworks. More 




 First, the study gathered data on couples’ decision-making styles and their relation 
to making FP decisions. This concept may be explored further using psychosocial 
analysis and surveys with couples to explore the nature of their relationship and the stress 
they undergo while making FP decisions. 
 Second, the research offers opportunities to refine the themes and concepts that 
emerged from the data further, for example, couples’ responses to the infertility news. It 
also is possible to explore various components of their responses in further detail. 
Researchers may time the interviews after breaking the news and collect data by 
videotaping and recording the couples’ discussions. Other themes, for example, the need 
for biological children and spouses’ attribution about the way the patient feels about 
having children also may be explored in future research.  
 A longitudinal study could be conducted that follows couples from the time they 
learn that their fertility may be compromised to when they make a choice and a year 
thereafter to collect data on their satisfaction with their FP decision.  
 Finally, as stated in the limitations, this research was limited to non-distressed 
relationships and heterosexual couples. Further research with same-sex couples and those 
that may be in distressed relationships can increase our knowledge about this complicated 
decision-making process further.  
Implications for Oncofertility Clinical Practice 
  This study will inform the oncofertility practice as it tries to develop couples’ 
interventions, including FP DAs for patients, clinical practices, couples’ counseling, and 
other similar support for patients who are making FP decisions. Oncology providers may 
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invite women to consider their spouse/domestic partners’ roles and potential needs during 
their introduction to FP. For example, they may introduce the concept of deciding who 
will be involved in the deliberation process versus who will be involved in making the 
final decision. Similarly, fertility specialists may wish to advise women to invite their 
spouses/partners to attend the FP consultation, and assess the desired roles and 
informational needs of the couple and each individual purposefully. Results from this 
study may inform the design of a DA that tailors information and decision-making 
support to women and their spouse/domestic partners. DA developers may wish to assess 
whether the themes couples identified in this clinical context apply to their clinical 
context. These findings may help support high-quality decision-making for each 
individual and enhance further the quality of couples’ informed consent consistent with 
the legal and policy requirements for many FP therapies. As efforts continue to create 
certification criteria for patient/family DAs, additional criteria may be needed that 
address the roles and needs of couples making decisions specifically. 
 The study also recommends that clinicians counsel couples when they contact 
fertility clinics. The focus of the counseling certainly always will be on the patient, but 
spouses/partners need support and information, too. Understanding the needs and wants 
of patients’ spouses/partners and addressing both is critical in providing holistic care to 
the patients.  
Implications for Social Work Practice 
 As social workers, we are trained to attune ourselves to the clients’ environment 
and understand their family support to provide adequate help. In the case of FP, spouses/ 
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partners are a significant element of this environment. This research informs social 
workers about the complications associated with making FP decisions and directs them to 
plan interventions for the couple as a whole. They also serve as liaisons between different 
institutions and help couples collaborate with various providers while making FP 
decisions. As the literature review stated that social workers may be navigators for 
oncology patients, because they are working through the case and helping patients with 
their options, this research informs them about the process and interactions between 
couples as they make FP decisions. Social workers need to be mindful of the fact that, 
although the patient may be the primary decision maker in most cases, spouses do play a 
supportive role in decision-making. 
 Social workers also might find it helpful to explore and map the couples’ general 
decision-making process and what they deem most important in it. They also can explore 
couples’ backgrounds and values that may influence FP decision-making. Further, social 
workers should be aware of their ethical dilemmas, as they may be more attuned to 
couples’ interactions during case work sessions. As the study suggests that couples do 
complete each other’s narratives and contradict them at times, by paying attention to 
these, social workers can obtain better insight into the couples’ lives and their affect. A 
discussion about how strongly one feels about having biological children can help 
couples explore their motivations and reasons for engaging in FP.  
This is one of the first studies to explore couples’ decision-making in the area of 
FP; further research needs to be performed to replicate the results and achieve a deeper 
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understanding of spouses/partners’ responses to infertility and their roles in the decision-
making process.  
Implications for policy 
 The ASCO publishes guidelines for providers in the field of oncofertility, and its 
recommendations cover discussions with patients to facilitate FP decision-making. This 
research underscores the importance of including spouses in these discussions, and in 
future updates, these recommendations may suggest to include spouses more when 
providing support to their patients.   
 There is ongoing lobbying for federal legislation that requires insurers to cover FP 
when cancer treatments result in infertility. One may argue that FP care is not lifesaving 
and that FP techniques are experimental. But according to Cardozo et al., (2017) even 
though infertility may not be life threatening but fertility preservation is ‘life affirming’, 
and FP consultation reduces long term regrets and improve patients’ quality of life. This 
reduces mental health issues evolving in later life of the patients.  FP technology has 
advanced significantly and cryopreservation of embryos, oocytes, and spermatozoa are 
established techniques (“Ethics Committee of the American Society for Reproductive 
Medicine”, 2013).  They are no longer considered experimental. The results from the 
current study underlines the ‘life affirmation’ and reduced long term regrets aspects of FP 
consultation. Hence, it supports legislations in favor of covering these consultations 
through insurance. 
According to the Declaration of Rights of People with Cancer, shared decision 
making is a fundamental right of cancer patients (Speechley & Maxine, 2001). FP 
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consultation with patients and their spouses is imperative to shared decision making.  
This study depicts how patients feel about FP decision making with their spouses and 
supports the patients’ rights to shared decision making. Through my study I would argue 
that the involvement of spouses if patients’ want is a right under shared decision making 
for the patients. Providers not only need to involve patients but also their spouses/partners 
while doing FP consultations with patients’ will.   
Overall for policy makers it is imperative to know the will of cancer patients and 
their needs while getting cancer treatment and its influence on post treatment life. My 
study explores the importance of FP and FP decision making of the young patients with 
cancer. This literature is important to support future policies, promoting FP consultations 
and shared decision making among young couples.  
Limitations 
The objective of the study was to understand the roles of spouses/partners in FP 
decision-making. The findings may support couples who are undergoing similar 
treatment and have to make such decisions. However, this research has several 
limitations: 
1) The study was conducted by recruiting patients from the same facility using a 
convenience sample. Hence, there is a sampling limitation. However, it is a diverse 
sample with multiple ethnicities and other demographic characteristics.  
2) Interviews were conducted over the phone to accommodate patients from 
different cities who came to the facility for treatment. Phone interviews do miss body 
language and other interactive advantages that one may derive in an in-person interview. 
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3) The study did not include same-sex couples and lacked their input.  
4) All couples that were studied reported non-distressed relationships. The 
dynamics of decision-making change if couples are distressed.  
5) There are limitations to dyadic interviewing. Couples may provide 
confirmatory accounts of their share of stories, as these interviews constitute a 
presentation to the researcher. Thus, they may avoid expressing their differences or 
challenging each other.  
6) As the samples of patients were limited to same-sex, non-distressed couples, 
the results may not be generalized to same-sex and distressed couples.  
Although there were limitations to the study, it may be used to further research on 
couples’ decision-making, particularly studies that explore such areas as 
spouses/partner’s relationships and response to potential loss of fertility that may 
influence fertility decision-making.  
Conclusion 
This qualitative study explored the way couples make FP decisions and the roles 
spouses/partners play in those decisions. Four major themes, the couples’ response to 
potential fertility loss, spouses/partners’ roles, ethical/legal concerns, and 
recommendations for other couples emerged from the data.  
Patients make choices for themselves, but spouses do play significant roles in 
decision-making. What couples deem important in all manners of topics also influences 
their FP decisions. Spouses/partners’ recommendations to other couples suggested that it 
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is important to show concern for the patient/spouse/partner and to attend at least one 
fertility consultation.  
Through the joint interviews, this study also demonstrated that spouses/partners 
do disagree with patients sometimes during this decision-making and may find their 
disagreements difficult to express, especially in front of their spouses. This highlights the 
importance of attending to what spouses/partners may undergo when making FP 
decisions. They do have emotional needs and play a significant role in FP decisions. 
Thus, providers should not ignore them while helping patients in the FP decision-making 
process. Patients alone are not the only stakeholders in this extremely critical decision, 
and they do depend on their spouses/partners to make it. There is considerable scope for 
further research in this field, including looking more closely at spouses/partner’s values, 
their response to potential fertility loss, religious preferences, and the couple’s 
relationship and its effect overall.   
This area of research is new, and the goal is to provide more support to patients as 
they make FP decisions by understanding how central the patient’s significant other is in 




Tables and Figures 
Table 1. Participants’ sociodemographic information 
Individual characteristics % (n) 
Male  
White 83% (10) 
Black 8% (1) 
Asian  0% (0) 
Hispanic 8% (1) 
Age, Mean (max, min) 35 (30-45) 
Religion  
Christian (Catholic) 0 
Christian (Protestant) 16% (2) 
Christian (other) 58% (7) 
Atheist/Agnostic 8% (1) 
Other 16% (2) 
Education  
Some college 25% (3) 
Bachelor’s 41% (5) 
91 
 
Master’s 16% (2) 
Doctoral 16% (2) 
Female  
White 66% (8) 
Black 8% (1) 
Asian  8% (1) 
Hispanic 16% (2) 
Age, Mean (max, min) 34.9 (28-45) 
Age at diagnosis, Mean (max, min) 32.9% (27-43) 
Religion  
Christian (Catholic) 0 
Christian (Protestant) 8% (1) 
Christian (other) 25% (3) 
Atheist/Agnostic 42% (5) 
Other 25% (3) 
Education  
Some college 16% (2) 
Bachelor’s 58% (7) 
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Master’s 8% (1) 
Doctoral 16% (2) 
Couples  
No. of couples with biological children together 41% (5) 
No. of couples with children from other partners 8% (1) 
No. of couples expecting at time of interview 8% (1) 
No. of couples with no children 50% (6) 
Marital Status  
Married 75% (9) 
Living together 25% (3) 
Median household income (min, max) $150,000 (57,000-400,000) 
Relationship Status  
Distressed/Non-distressed 
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Figure 3. Diagram of themes anchored in Ottawa Decision Support Framework 
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Study ID #: ______ 
Date/Time#: 
Please complete these questions by marking an X next to the answer that best describes 
you or by filling in the blank. These questions are for research purposes only and your 
answers will be kept strictly confidential. 
                      
1.       How old are you currently? 
______ Years 
  
2.       How old were you when you were diagnosed with cancer? 
______ Years 
  
3.       What is your race? Please check all that apply. 
______ American Indian or Alaska Native 
______ Asian 
______ Black or African American 




______ Other:  ______________________________ 
  
4.        What is your ethnicity? 
______ Hispanic or Latino 
______ Not Hispanic or Latino 
  
5.       What is your household income per year (in US dollars)? 
$___________________ per year 
  
6.       What religion do you most closely identify with? 
______ Atheism/Agnosticism 
______ Buddhism 
______ Christianity (Protestant) 
______ Christianity (Catholic) 










7.       What is the highest grade/level of education that you have completed? 
______ Less than high school 
______ High school (grades 9-12, no degree) 
______ High school graduate (or equivalent) 
______ Some college (no degree) 
______ Associate’s degree (including occupational or academic degrees) 
______ Bachelor’s degree (BA, BS, AB, etc.) 
______ Master’s degree (MA, MS, MSW, etc.) 
______ Professional school degree (MD, DDC, JD, etc.) 
______ Doctoral degree (PhD, EdD, etc.) 
  
8.       Please check the relationship category that best describes your situation 
currently. 
______ Single 




______ Other—Please describe: ______________________________ 
  





______ With spouse 
______ With opposite sex partner (unmarried) 
______ With same sex partner (unmarried) 
______ With others (e.g., friends, family) 
  
10.   Please check the relationship category that would best describe your situation 
when you were diagnosed with cancer. 
______ Single 









11.   Please check the category that best describes your living arrangements when 
you were diagnosed with cancer. 
______ Alone 
______ With spouse 
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______ With opposite sex partner (unmarried) 
______ With same sex partner (unmarried) 
______ With others (e.g., friends, family) 
  
  
Approximately when did you learn about cancer diagnosis-? 
Have you been for first fertility consultation: No        Yes? 
If yes then approximately when: 
  
Number of biological children with the current spouse: ____________________ 
Number of biological children from previous marriage (if any): 
Number of children who stay with you in the household 
  
How is your relationship with your spouse? Is it distressed or not distressed from before 
cancer diagnosis 
  
How would you describe the relationship now? Distresses and not distressed 
  
  
How many children do you think you want to have? 
  








I would like to invite both of you an hour and half   interview. I would like to learn more 
about how you and your spouse are trying to reach to FP decision.  I want to know about 
your experiences, conversations and discussions on fertility preservation and how is this 
impacting your relationship? 
I will ask you both some questions together and then will interview the partner 
individually without the presence of the patient. 
CONJOINT INTERVIEW 
1)      What is most important to you in making decisions in your relationship…? 
(Examples: mutual 
Satisfaction, equity, fairness, shared communication, etc.). 
·         What does _____ mean to each of you? 
·         How do you define ____ in your relationship? 
·         Help me to understand ____ in your decision-making 
·         What does ____ look like? 
·         How do you make decisions in this way? 
2) How does this apply to your current problem of FP decision-making? 
·         Is it different from other decisions? 
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·         What makes it different? 
3) How do you work it out when you disagree on a decision? 
·         What does that process look like? 
·         What happens next? 
4) What were the disagreements in FP decision-making? 
·         How did differ in your opinion? 
4) How did you work out your disagreements in FP decision-making? 
Prompts; is it different to work it out this time than you usually do for other major 
decisions 
5) Tell me about a time when you made a decision where both of you were satisfied. 
6) How and when you both reached an agreement and were satisfied about FP decision? 
7) Tell me about a time when both of you together made a medical decision together 
apart from FP? 
Prompts: Can be about having kids? Any surgery? Or any other major decision linked to 
the health of either partner. 
8) How is the situation similar or different in FP decision-making than any other medical 
decision in the past? 
Prompts: Involvement, unpredictability, lack of information. 
 9) What are strengths and weaknesses of your relations that helped or hindered FP 
decisions? 




1.   Can you describe what happens when you first came to know about fertility 
compromise of your spouse? 
Prompts: Who talked to you? When was this discussed? Were there other family 
members when you first came to know? 
2.   How important is it to you that your partner be able to have her own biological 
child in the future? 
Prompts: Family lineage, attachment to the child, family acceptance. 
3.   How important is it to you that you be able to have your own biological child in 
the future? 
Prompts: Would you be comfortable with a child conceived from your sperm but an egg 
from a donor? Would you be comfortable adopting a child? 
DEFINING FERTILITY PRESERVATION AND INFORMATION 
  
4.      Tell me in your own words what fertility preservation is. 
5.      Before your spouse began [cancer] treatment, did you know that there is an option of 
pursuing fertility preservation? 
Prompts; 
·         How did you first hear that you both could pursue fertility preservation? 
·         When you learned that your partner/spouse could pursue fertility 
preservation, what were your first thoughts? 
6.   What do you think will happen to your partner after cancer treatment? 
Prompts: Emotional issues, physical issues 
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7.   What do you think is likely to happen to your partner’s fertility after her cancer 
treatment? 
Prompts: Were you included in discussions with the doctors about fertility? Do you feel 
comfortable with the amount of information you have? 
8.   What do you think are the main advantages of your partner going through fertility 
preservation? Or not going through fertility preservation. 
Prompts: How can the family benefit from FP? Does it bring hope, confidence to the 
family? 
9.   What will happen if you moved forward with it? Or if you do not do this. 
10.  Do you have some worries or concerns about your partner going through fertility 
preservation? 
Prompts: Do you worry it could delay her cancer treatment too much? Are you worried 
about the cost? 
SUPPORT IN DECISION-MAKING 
11.  What do you think should be your role in the decision about fertility preservation? 
Prompts: Should it be her choice alone? Should you have some say in her choice? Should 
each partner have an equal say? 
12.   What do you think your partner wants to do about fertility preservation? 
Prompts: how do you think she wants to proceed with it? 
13.  Who will make this final decision? 
Prompts: Is it going to be just you two or other family members will be involved? 
14.  Do you have any religious or legal concerns about fertility preservation? 
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15.  Lastly I would like to ask if you received the support from the providers to make this 
decision. 
16. How do you think Oncofertility consultation can involve spouses more? 
a.       Prompts- support that spouses need to reach a decision 
CLOSING 
“If there is anything we have not discussed and you feel it would be important to add to 











INFORMED CONSENT/AUTHORIZATION FOR PARTICIPATION IN 
RESEARCH WITH OPTIONAL PROCEDURES 
Study- Role of spouse/partner in fertility preservation decision-making by young women 
with cancer. 
Researcher- Aakrati Mathur                                   Study chair- Dr. Terri L. Woodard 
Participant’s name: __________________ 
Check relation to the patient with Cancer: Self or Spouse/domestic partner 
Medical Record number/Study Id___________________ 
Email address_______________ 
Phone Number___________________ 
You are being asked to take part in this psychosocial research study at The University of 
Texas MD Anderson Cancer Center ("MD Anderson"). This consent and authorization 
form explains why this research study is being done and what your role will be if you 
choose to take part. This form also describes the possible risks connected with being in 
this study. After reviewing this information with the person responsible for your 
enrollment, you should know enough to be able to make an informed decision on whether 
you want to take part in the study. 
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You are being asked to take part in this study because you are the woman or 
spouse/domestic partner of a woman between the ages of 18 and 45 who has been 
diagnosed with cancer. 
1)      Purpose of the Study 
The goal of this research study is to collect information about factors that influence 
decisions about fertility preservation from women between the ages of 18 and 45, who 
have been diagnosed with cancer and their spouses. The main objective is to understand 
the role of partner in fertility preservation decision-making by focusing on their 
preferences on fertility preservation methods, whether they are aware of the various 
methods and how their future family goals compare with that of their women 
counterparts.  Fertility preservation involves taking drugs to stop or control ovary 
function in order to freeze eggs and/or embryos. Freezing eggs and/or embryos may 
increase the chances of having a biologic child in the future. 
The information collected from this study will be used to create a booklet and web-based 
informational aid that may help future patients make decisions about fertility 
preservation. 
DESCRIPTION OF STUDY 
If you agree to take part in this study, you will have a telephonic interview with a 
member of the study. There will be one 45 minute interview conjoint with your spouse 
and one 45 minute individual interview without the presence of the spouse. Before you 
take part in an interview you will complete 1 questionnaire about your age, sex, education 
level and other demographic information. These should take about 10 minutes to 
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complete. This questionnaire will be emailed to you. You will provide your phone 
number in the email and times when you are available for interview.  In the interview you 
will be asked up to 20 questions about your relationship and what factors influenced your 
decision-making process about fertility preservation, such as personal attitudes, belief 
systems, and financial considerations. The interview should take about 1 hour. 
This is an investigational study and will be of no cost to you. 
4. RISKS, SIDE EFFECTS, AND DISCOMFORTS TO PARTICIPANTS 
You should discuss the risks of interviews and questionnaires with the study chair. The 
known risks are listed in this form, but they will vary from person to person. Some 
questions may make you feel upset or uncomfortable. You may refuse to answer any 
question. If you have concerns about completing the questionnaires or participating in 
interview, you are encouraged to contact your doctor or the study chair. Although every 
effort will be made to keep study data safe, there is a chance that your personal health 
information could be lost or stolen. All study data will be stored in password-protected 
computers and/or locked file cabinets. There will be no personal identifying information 
connected to your questionnaire and interview. The study data will be destroyed right 
after the study has been published. 
This study may involve unpredictable risks to the participants. 
5. POTENTIAL BENEFITS 
Future patients may benefit from what is learned. There are no benefits for you in this 
study. 
6. ALTERNATIVE PROCEDURES OR TREATMENTS 
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You may choose not to take part in this study. 
OPTIONAL PROCEDURES FOR THE STUDY 
If you agree, the research staff may contact you by phone or mail to ask if you would be 
interested in taking part in future research studies. There are no benefits to you for taking 
part in the optional procedure. You may stop taking part at any time. There will be no 
cost to you for taking part in the optional procedure. You do not have to agree to take part 
in the optional procedures in order to be enrolled in this study. 
Optional Procedure Risks: 
If you are contacted about future studies, other people may learn that one family member 
(Had) cancer. This may be upsetting. 
Circle your choice of “yes” or “no” for each of the following optional procedures: 
Do you agree to allow the research staff to contact you to ask if you would be? 
Interested in taking part in future research studies? 
YES                                                                                             NO 
  
Additional Information 
7. You may ask the study chair any questions you have about this study. You may contact 
the study chair, Dr. Terri L. Woodard, at 713-745-7591. You may also contact the Chair 
of MD Anderson's Institutional Review Board (IRB - a committee that reviews research 
studies) at 713-792-2933 with any questions that have to do with this study or your rights 
as a study participant. 
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8. Your participation in this research study is strictly voluntary. You may choose not to 
take part in this study without any penalty or loss of benefits to which you are otherwise 
entitled. You may also withdraw from participation in this study at any time without any 
penalty or loss of benefits. If you withdraw from this study, you can still choose to be 
treated at MD Anderson. 
9. This study or your participation in it may be changed or stopped at any time by the 
study chair, The University of Texas MD Anderson Cancer Center Duncan Family 
Institute, or the IRB of MD Anderson. 
10. You will be informed of any new findings that might affect your willingness to 
continue taking part in the study. 
11. MD Anderson may benefit from your participation and/or what is learned in this 
study. 
12. This study is supported by: The University of Texas MD Anderson Cancer Center 
Duncan Family Institute 
STUDY COSTS AND COMPENSATION 
If you suffer injury as a direct result of taking part in this study, MD Anderson health 
providers will provide medical care. However, this medical care will be billed to your 
insurance provider or you in the ordinary manner. You will not be reimbursed for 
expenses or compensated financially by MD Anderson or The University of Texas MD 
Anderson Cancer Center Duncan Family Institute for this injury. You may also contact 
the Chair of MD Anderson’s IRB at 713-792-2933 with questions about study-related 
injuries. By signing this consent form, you are not giving up any of your legal rights. 
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Unless otherwise stated in this consent form, all of the costs linked with this study, which 
are not covered by other payers (health maintenance organization [HMO], health 
insurance company, etc.), will be your responsibility. There are no plans to compensate 
you for any patents or discoveries that may result from your participation in this research. 
If you are the spouse/domestic partner of the woman with cancer you may be given a $10 
gift card for your time and effort in completing the interview. 
Authorization for Use and Disclosure of Protected Health Information: 
A. During the course of this study, the research team at MD Anderson will be collecting 
Information about you that they may share with the parties named in Section D below. 
B. Signing this consent and authorization form is optional. However, if you refuse to 
provide authorization to use and disclose your protected health information for this study, 
you will not be able to participate in this research study. 
C. MD Anderson will take appropriate steps to keep your protected health information 
private when possible, and it will be protected according to state and federal law. 
However, there is no guarantee that your information will remain confidential, and it may 
be re-disclosed at some point. Federal agencies (such as the Office for Human Research 
Protections [OHRP – a regulatory agency that oversees research in humans]), The 
University of Texas MD Anderson Cancer Center Duncan Family Institute, and the IRB 
of MD Anderson might view or receive your record in order to collect data and/or meet 
legal, ethical, research, and safety-related obligations. In some situations, health 
authorities could be required to reveal the names of participants. 
D. Your study information may be shared with the following parties: 
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·         The University of Texas MD Anderson Cancer Center Duncan Family Institute 
·         (and/or any future sponsors of the study) 
·         The OHRP 
·         The IRB of MD Anderson 
·         Officials of MD Anderson 
·         Study monitors who verify the accuracy of the information including Portland State 
University faculty member involved in the research 
·         Individuals who put all the study information together in report form 
E. Normally you have a right to access your study information. However, in order to 
preserve the integrity of this research study, you will not be permitted to have access to 
certain portions of your study information while the study is ongoing. 
F. There is no expiration date for the use of your information as stated in this 
authorization. You may withdraw your authorization to share your protected health 
information at any time in writing. Instructions on how to do this can be found in the MD 
Anderson Notice of Privacy Practices (NPP). You may contact the IRB Staff at 713-792-
2933 with questions about how to find the NPP. If you withdraw your authorization, you 
will be removed from the study and the study chair and staff will no longer use or 
disclose your protected health information in connection with this study, unless the study 
chair or staff needs to use or disclose some of your research-related protected health 
information to preserve the scientific value of the study. Data collected about you up to 
the time you withdrew will be used and included in the data analysis. The parties listed in 
130 
 
Section D above may use and disclose any study data that were collected before you 
canceled your authorization. 
CONSENT/AUTHORIZATION 
I understand the information in this consent form. I have had a chance to read the consent 
form for this study, or have had it read to me. I have had a chance to think about it, ask 
questions, and talk about it with others as needed. I give the study chair permission to 
enroll me on this study. By signing this consent form, I am not giving up any of my legal 
rights. I will be given a signed copy of this consent document. 
  
__________________________                                                                
 _____________ 
Signature of Participant                                                                                             Date 
  
PERSON OBTAINING CONSENT 
I have discussed this psychosocial research study with the participant and/or his or her 
authorized representative, using language that is understandable and appropriate. I 
believe that I have fully informed this participant of the nature of this study and its 
possible benefits and risks and that the participant understood this explanation. 
________________________ 
SIGNATURE OF STUDY CHAIR 
OR PERSON AUTHORIZED 
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IRB Approval 
